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Melanoma is the deadliest form of skin cancer, and rates of melanoma in the UK appear to be 
rising. Despite this increase, current diagnostic methods remain slow, invasive and speculative. 
In this work, surface enhanced Raman spectroscopy (SERS) is proposed as an alternative 
diagnostic method, with the potential to provide rapid, point-of-care testing for early-stage 
melanoma skin cancer.  
Gold nanostars decorated with red and near infrared-absorbing dyes were designed and 
synthesised as probes for surface enhanced resonance Raman spectroscopy (SERRS). Various 
dyes were evaluated as potential reporter molecules; methylene blue was chosen for the final 
probe structure due to its clear SERS signals and superior stability when bound to the nanostar 
surface. The probe was coated with a protective silica layer and functionalised with a peptide 
for the selective targeting of melanoma, before testing with various mammalian cell lines. 
The results show that human melanoma cells dosed with the SERS probe retained SERS signals 
after rinsing with water, whereas the probe appeared to ‘rinse out’ of other cell lines, giving 
significantly diminished SERS signals. Confocal and fluorescence microscopy images also 
show the adhesion of the probe to human melanoma cells.  
Following the success of this method, alternative reporter molecules were investigated. 
Namely, the use of molecular wires as potential Raman reporters was explored, as it was 
theorised that the conductive properties of these molecules could augment the SERS effect. 
The wires were synthesised and adhered to the surface of gold nanostars, in order to evaluate 
the effect of wire length on SERS intensity. The SERS spectra of the molecular wire-
functionalised gold nanostars did not display improved signal intensity compared to gold 
nanostars functionalised with shorter molecules. These experiments were largely hindered due 
to instability of the wire-functionalised gold nanostars in solution, and so to fully rule out the 
possibility of molecular wire augmented SERS, work would need to be done to find a wire-
functionalised substrate less prone to aggregation.  
The observations herein demonstrate that a selective probe for the detection of melanoma, 
based on methylene blue decorated gold nanostars, was successfully created. While the 
preliminary results of this study indicate that the SERS method is a viable approach for 
melanoma detection, further optimisation of the probe is required for clinical applications. In 
particular, strategies to improve the SERS signal intensity are discussed. 
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SERRS Surface enhanced resonance Raman spectroscopy 
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SM Single molecule 
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SPM Scanning probe microscopy 
SPR Surface plasmon resonance 
TBAT Tetrabutylammonium difluorotriphenylsilicate  
TEM Transmission electron microscopy 
TEOS Tetraethyl orthosilicate 
TERS Tip enhanced Raman spectroscopy 
TIR Total internal reflection 
UV-Vis Ultraviolet-visible 
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α-MSH Alpha-melanocyte stimulating hormone 
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Cutaneous melanoma is the fastest-rising form of cancer in the UK in the past 30 years, and 
mortality rates continue to increase.1 However, current diagnostic tests for melanoma involve 
skin biopsy, which is a slow and invasive method.2 Surface enhanced Raman spectroscopy 
(SERS) could potentially provide an alternative diagnostic technique to identify melanoma. 
SERS is based on exploiting the effect of plasmonic metal surfaces to enhance the signal from 
Raman scattering, which is otherwise weak.3 Small concentrations of molecules and indeed 
even single molecules can be detected with great accuracy using SERS.4 Since its initial 
discovery in 1974,5 SERS has become an increasingly popular analytical method, widely 
utilised in a variety of applications such as the detection of pesticides and explosives.6,7  The 
ability of SERS to detect small amounts of analyte in a non-invasive way makes the method an 
attractive possibility for use in early stage diagnostics, including in the detection of melanoma.8 
However, the use of SERS in medical applications remains limited at present, and a number of 
factors must be taken into account when designing a SERS probe for the purpose of medical 
diagnosis. In the following chapter, the concept of SERS and its potential uses in medical 
diagnostics are explored, and current methods for the diagnosis of melanoma are evaluated in 
comparison to SERS. 
 
1.1 Raman Spectroscopy 
 
When incident light interacts with a particle, the majority of photons are scattered elastically, 
neither gaining nor losing energy. 9 Elastic scattering can fall into one of two categories; 
Rayleigh scattering, in which the particle is smaller than the wavelength of incident light 
(approximately one tenth of the wavelength), or Mie scattering, in which the particle is larger 
than the wavelength of incident light.10 .  
Raman scattering describes the small proportion of photons scattered inelastically, occurring 
for approximately one in every 106-108 photons.9,11 These photons either lose (Stokes 
scattering) or gain (anti-Stokes scattering) energy as a result of their interaction with the 
material. Raman scattering occurs when the electric field of the incident light polarises the 
electron cloud about the molecule (Figure 1.1), exciting it to a virtual state (Figure 1.2). Virtual 
states are not ‘real’ states of the molecule, but created when the molecule becomes polarised, 
although they can be thought of as a superposition of real states.  





Figure 1.1: Polarisation of a molecule induced by an electric field.  
 
 
Figure 1.2: Jablonski diagram showing Raman and Rayleigh scattering, with other 
photochemical processes for comparison.  
 
Raman scattering therefore depends on a change in polarizability of the molecule; this is the 
basic selection rule of Raman spectroscopy. This is in contrast to infrared spectroscopy, which 
is dependent on the dipole moment of the molecule; a change in the dipole moment results in 
the molecule being excited to a higher vibrational energy level. On a basic level, these selection 
rules mean that symmetrical molecules will give more intense Raman scattering, whereas 
asymmetrical molecules are more suited to IR spectroscopy. Examples of these selection rules 
applied to the bond vibrations of  CO2 are given in Figure 1.3. 
9,11,12 





Figure 1.3: Bond vibrations of CO2, demonstrating selection rules for this molecule. Arrows 
indicate the net dipole moment of the molecule (if non-zero). 
 
1.2 Surface plasmons and the SERS effect 
 
Despite being discovered in 1928,13 Raman spectroscopy did not take off as a characterisation 
technique until much later in the century, partially due to advancement in instrumentation, and 
also due to the discovery of the surface enhanced Raman effect in 1974,5 which allowed the 
relatively small signals of Raman spectroscopy to become greatly enhanced. This enhancement 
effect, first observed on silver electrodes, can be attributed to surface plasmons present on 
metal surfaces.5,14 
 Surface plasmons (SPs) can be described as a wave of oscillating electrons induced by incident 
light. SPs can be sorted into two types: propagating surface plasmons (PSPs) and localised 
surface plasmons (LSPs).15 PSPs are induced by incident light on a metal surface under total 
internal reflection (TIR) conditions, and propagate parallel to a metal surface, at the interface 
between the metal and dielectric material. LSPs occur in metal colloidal suspensions and as the 
name suggests, do not propagate but are confined to a space which is similar in length or smaller 
than the excitation wavelength: they are confined to a nanoparticle. LSPs are induced by 
incident light, causing the oscillation of electrons in the conduction band. Both these types of 
SP are shown in Figure 1.4, though the SERS effect is primarily affected by LSPs. 





Figure 1.4: Schematic diagram of LSPs in metal nanoparticles (top) and PSPs along a metal-
dielectric interface under TIR conditions (bottom).  
 
Metal surfaces are able to efficiently enhance signals in Raman spectroscopy, in a technique 
known as surface enhanced Raman spectroscopy (SERS). There are two known mechanisms 
by which this enhancement occurs: electromagnetic enhancement, and charge transfer.16  Since 
the Raman effect depends on the induced dipole of the molecule μ, which relates to the electric 
field E and polarizability of the molecule α (equation 1.1), these mechanisms are concerned 
with the effect of the metal surface on α and E, respectively. 
                                                                   𝜇 =  𝛼𝐸                                                           (eq. 1.1) 
The electromagnetic enhancement theory focuses on the effect of the metal on E, and can be 
understood by considering LSPs.17,18 Incident light induces LSPs, which have an associated 
electric field as shown in Figure 1.3. This LSP field couples with the electric field of the 
incident light E0, creating a greater, localised field at the metal surface ELoc. Molecules at the 
metal surface which experience this increased electric field have a greater induced dipole, 




hence more intense Raman scattering. The local field intensity enhancement factor (LFIEF) is 
defined in equation 1.2.  




                                                          (eq.1.2) 
In addition, the LSP field couples with the electric field of the Raman scattered radiation ER, 
further increasing intensity, since the intensity of light is proportional to the square of its 
electric field.16–18 This relationship is shown in equation 1.3 where I is intensity, ɛ0 is the 
permittivity of free space, c is the speed of light and E is electric field strength. The radiation 
enhancement factor is defined in equation 1.4.19 




                                                          (eq. 1.3)                              




                                                          (eq. 1.4) 
The overall SERS enhancement factor EF is often defined as being the product of these two 
enhancement factors (equation 1.5).17 However, it is often assumed that LFIEF ≈ REF, 
simplifying the expression (equation 1.6). For this reason, SERS is said to enhance Raman 
signals by an approximate factor of E4. 







                                                        (eq. 1.5) 




                                                        (eq. 1.6) 
SERS is often only observed experimentally when a metal surface has nanoscale features or 
‘nanoscale roughness’.12 When confined by crevices, such as the meeting point of two particles, 
LSPs can interact to form areas of highly localised, intense electromagnetic fields. These points 
areas are known as ‘hotspots’;20 where Eloc and hence the overall SERS enhancement can be 
particularly large.   
The charge transfer mechanism considers the effect of the metal on α, the polarizability of the 
molecule.16–18  This mechanism only applies when a molecule is chemically bonded to the 
surface, and is not observed in physisorbed molecules. The simplest explanation of this 
mechanism is that the bound molecule forms a charge transfer complex with the metal, which 
has greater polarizability than the unbound molecule, and hence exhibits more intense Raman 
scattering. The charge transfer enhancement is thought to have a relatively small contribution 




to overall signal enhancement, and only ever occurs alongside the electromagnetic mechanism. 
The EM mechanism on the other hand can occur independently and is thought to give the 
largest contribution to the SERS effect. 
 
1.3  Related SERS techniques 
 
The SERS effect can be enhanced further when using appropriate substrates and techniques. A 
common example is the Surface enhanced resonance Raman effect, in which the excitation 
wavelength is matched with the absorption profile of the Raman reporter to yield greater signal 
enhancement. By using specially selected substrates, SERS is capable of detecting single 
molecules, and reproducible enough to allow accurate quantitative analysis. These methods are 
discussed in the following sections.  
 
1.3.1 Surface Enhanced Resonance Raman  
 
Surface enhanced resonance Raman (SERRS) was first reported by Stacy et al. in 1983 when 
recording the Raman spectrum of tris(bipyridine)ruthenium(II) chloride on a roughened silver 
electrode. It remains a popular technique due to the significantly improved enhancement factors 
produced.21 For example, the SERRS enhancement factor of rhodamine 6G is approximately 
between 107 and 108 times greater than the SERS enhancement factor of pyridine.16 Examples 
of Raman reporter molecules selected to utilise the SERRS effect are given in Section 1.5.1. 
SERRS is a technique in which the excitation wavelength used in the Raman experiment is 
closely matched to an electronic excitation of a molecule being examined, resulting in 
enhanced Raman signals.11,16,22,23 Exciting a molecule to a higher electronic state can result in 
some structural changes; if these changes result in increased polarizability, then Raman 
scattering will logically increase also. This enhancement can be explained by the Kramer 
Heisenberg Dirac (KHD) equation for polarizability (equation 1.7). Due to the size of this 
equation, terms are summarised in Table 1.1, for clarity. 
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α Molecular polarizability 
ρ Incident polarisation direction  
σ Scattered polarisation direction 
Σ Sum over all molecular vibronic states 
G Ground vibronic state 
I Vibronic state of the excited state 
F Final ground vibronic state 
L Exciting light 
Γ Lifetime 
ω Frequency 
r Dipole operator 
Table 1.1: Terms associated with the KHD equation 
 
The numerator describes the mixing of the excited and ground states I, G and F, representing 
the ‘virtual’ state (Figure 1.2). The resonance Raman effect can be best understood by 
considering the denominator.  Resonance Raman conditions are met when the energy 
difference between the ground and excited states is equal to the energy of the exciting light, 
i.e. when ωGI = ωL; this reduces the denominator of the first term to iΓI. Because frequencies 
are added in the second term, this denominator is large, hence the second term does not 
contribute significantly and can be ignored. The excited state involved in Raman scattering is 
virtual, and therefore unstable and extremely short lived, hence iΓl is small. Therefore, because 
the denominator of the first term is small, polarizability overall is large, giving increased 
Raman scattering.11 
 
1.3.2 Single molecule detection 
 
Perhaps the greatest appeal of SERS is the ability to detect small concentrations of analyte 
down to a single molecule, making it an attractive technique for fields such as medical 
diagnostics.24 Single molecule (SM) SERS was first observed in 1997 by Kneipp et al. and Nie 
et al., who recorded SM SERS spectra of commercially available dyes crystal violet and 
rhodamine 6G (Figure 1.5).4,25 Silver nanoparticles were used as SERS substrates, with 
aggregation of the particles creating hotspots required for intense SERS enhancement. The 




experimental set-up involved the preparation of low-concentration solutions, such that the area 
sampled by the Raman microscope contained approximately one dye molecule. 
 
 
Figure 1.5: Structures of crystal violet (left) and rhodamine 6G (right). 
 
SM SERS has proved to be an attractive technique for the study of catalytic activity, as the 
metal surface can act as both a SERS substrate and catalyst.26 For instance, SM SERS has been 
used to investigate the plasmon catalysed dimerization of p-nitrothiophenol (Figure 1.6) to 
form  4,4'-dimercaptoazobenzene.27 Zhang et al. controlled the amount of p-nitrothiophenol 
(pNTP) on the substrate down to the single molecule level to determine the effects of 
concentration on the reaction, and to determine if a reaction of the lone pNMP molecule would 
occur in the presence of the plasmonic metal surface, without other pNMT molecules to 
facilitate dimerization. Results showed that when isolated on a gold surface, the single pNMT 
molecule will undergo plasmon catalysed dissociation of the nitro group to form thiophenol, a 
reaction which could not have been identified or observed without SM SERS. 
 
 
Figure 6: Structure of p-nitrothiophenol 
 
SM SERS has also proven useful for monitoring electrochemical reactions of single molecules 
at electrode surfaces.28 The first instance of this was in 2010, when the oxidation of Nile blue 
(Figure 1.7) adsorbed on a silver electrode was observed at the single-molecule level, using 




silver nanoparticles deposited on the electrode surface as a SERS substrate.29 As the field of 
molecular electronics expands, SM SERS has become valuable for studying the 
electrochemical properties of single molecules. 
 
 
Figure 1.7: Structure of Nile blue. 
 
 Although SM SERS opens up new possibilities for SERS, there is a major flaw in the 
technique; uncertainty over the number of molecules bound to the substrate makes it difficult 
to determine whether the SERS spectrum truly shows single molecules, or several.30 In 
addition, the aggregation of the substrate can produce non-homogenous aggregate clusters, 
lowering reproducibility. In recent years, progress has been made to improve these 
uncertainties; for example, the use of Langmuir-Blodgett films to control the amount of analyte 
bound to the SERS substrate.24 Another technique which provides single-molecule SERS with 
greater accuracy is tip enhanced Raman spectroscopy (TERS). TERS is a technique combining 
Raman spectroscopy with  scanning probe microscopy (SPM) techniques, such as atomic force 
microscopy.26 In this method, the tip of the cantilever used for the SPM experiment doubles as 
a SERS substrate, as shown in Figure 1.8. This usually involves either coating the tip with 
silver or gold, or modifying the tip with a nanoparticle.31 Because the only SERS substrate 
present is the single tip, and the molecules in the immediate vicinity of the tip can be identified 
using SPM, it is possible to confirm whether Raman spectra arise from a single molecule or 
several molecules.32 This technique was first observed by Stöckle et al. to acquire SM TERS 
spectra of the dye brilliant cresyl blue.33  





Figure 1.8: Typical TERS experimental setup.  
 
Like standard SM SERS, SM TERS has also proven useful in monitoring electrochemical 
reactions.26 In addition, TERS method has been successfully deployed to analyse the structures 
of biological samples, such biomembranes and DNA.34,35 One notable example is the use of 
TERS to examine protein fibrils.36 Amyloid fibrils are protein aggregates associated with 
neurological conditions such as Alzheimer’s disease and Parkinson’s disease. Fibrils such as 
these can be formed by insulin; these insulin fibrils are observed in conditions such as type II 
diabetes. Despite their important role in various diseases, the exact surface structure of these 
fibrils was until recently unknown. Using TERS, Kurouski et al. were able to determine that 
the outer surfaces of insulin fibrils are comprised mainly of α-helices and unordered protein 
structures, contrary to the previous belief that the surface was predominantly made up of β-
sheets; a significant breakthrough for research into neurodegenerative and insulin-pertaining 
diseases.  
 
1.3.3 Quantitative SERS analysis 
 
Research has been moving towards using SERS as a quantitative method. Although SERS is a 
highly sensitive technique capable of detecting single molecules, quantitative analysis of 
samples remains challenging. This is mainly because SERS is inherently a localised technique, 
enhancing Raman scattering of molecules in close vicinity to hotspots; it is therefore difficult 
to analyse and quantify the sample as a whole. 37 Another issue is the uniformity of the SERS 
substrate, as signal enhancement can vary greatly if the substrate is not homogenous.38 In some 
cases, these problems can be circumvented with use of an internal standard. Known quantities 
of the standard, usually a molecule or nanostructure such as a carbon nanotube, are embedded 




in the substrate, and SERS signals of these standards are used to normalise signals from the 
analyte.38,39 
Another way to create uniformity is to create a SERS film with a homogenous structure across 
the entire surface area of the substrate.40 On such example is the use of gold nanoparticle coated 
polystyrene beads, immobilised on quartz. These substrates, fabricated by Péron et al., are 
capable of quantitatively detecting polycyclic aromatic hydrocarbons at concentrations as low 
as 1 ppm. However, the uncertainty of this detection system was shown to be around 30 %, 
highlighting the major drawback of SERS as a quantitative technique: reproducibility. This 
poor reproducibility was likely caused by the irregular clusters of gold nanoparticles which 
formed on the surface of the polystyrene beads. Therefore, in order to obtain good, reproducible 
quantitative SERS results, work must be done to fabricate more uniform substrates. 
Some promising quantitative SERS results have been obtained using similar, more uniform 
substrates. 41 The gold ‘film over nanoparticle’ substrates fabricated by Peksa et al., consist of 
a monolayer of polystyrene nanoparticles deposited on a silicon substrate and sputter coated 
with a 20 nm layer of gold. This substate was used to quantitatively measure amounts of the 
potentially harmful food colourant azorubine in soft drinks. By this method, amounts of 
azorubine as low as 0.5 mg dm-3 were detectable with good reproducibility within minutes, 
requiring no modification of the surface or treatment of the samples. This exemplifies of the 
rapid quantitative analysis SERS is capable of when an appropriate substrate is implemented.  
 
1.4 Intrinsic SERS Probes 
 
Non-selective SERS probes, known as intrinsic probes (Figure 1.9), are the simplest form of 
SERS substrate.42 The design of an intrinsic probe can be broken into three main components: 
metal, shape, and size. A summary of these three components is given in the following sections.  
 









Metals which support surface plasmons are alkali metals (Li, Na, K) and noble metals (Cu, Ag 
and Au).43 The surface plasmon wave is a phenomenon involving delocalised electrons of the 
metal surface,44 therefore, the ability of these metals to support SPs arises from their valence 
electron configurations.45  The alkali and noble metals each have an unpaired s electron, which 
is easily delocalised.44 These free electrons within the metal structure can, under the correct 
conditions, form plasmon waves, as described previously (Section 1.2). 
 
Of the noble or ‘coinage’ metals, silver displays the greatest enhancement factors, followed by 
gold, with copper giving the lowest SERS enhancement. 46  The differing enhancement effects 
of these metals can be explained by considering equation 1.8, which describes the polarizability 
of a metal sphere with radius R, where ωp is the plasmon resonance frequency, ɛb(ω) is the 
wavelength-dependent inter-band transition contribution to the dielectric function, and γ is the 
electron scattering rate.  
 






2] + 𝑖𝜔𝛾(ɛ𝑏+ 3)
                                           (eq.1. 8) 
 
Large polarizability and hence strong SERS enhancement occurs in metals where ɛb(ω) and γ 
are small, at the desired excitation wavelength (ω). This occurs in silver, gold, copper and 
lithium. Silver has the largest ɛb(ω) over most excitation wavelengths, resulting in a large SERS 




contribution, while ɛb(ω) for copper is relatively small over the same range, giving it weaker 
SERS enhancement.47 At around 600 nm, the SERS enhancement of gold is comparable to 
silver, as is lithium.   
 
Alkali metals are considered by most to be less suitable for SERS applications, due to their 
high reactivity in air.48 Coinage metals on the other hand are stable, give good SERS 
enhancement, and can be easily functionalised; thiols have a high affinity for gold, silver and 
copper surfaces, forming self-assembled monolayers which can be used to alter the properties 
of the surface to suit its purpose.49,50  
 
Silver substrates have been shown experimentally to give greater SERS enhancement than 
gold; for example, when recording the SERS spectra of crystal violet and adenine, Kneipp et 
al.  report enhancement factors approximately 100 times greater using silver nanoparticles than 
those obtained using gold nanoparticles.51 Due to the toxicity of silver nanoparticles, gold 
SERS nanoparticles are considered more useful for biological sensing applications.52 Gold 
substrates are also chemically inert,53 allowing their use in a range of systems without affecting 
the signal by chemically interacting with the analyte, although the mode of binding of the 
analyte to the gold surface may affect the signal enhancement. Gold nanoparticles are also more 
stable, as they are less readily oxidised.8 Copper substrates are generally less popular due to 
their poor enhancement factors compared to silver and gold.54 They are also less stable than 




A library of metal nanostructures  have been developed over the years with a variety of shapes, 
sizes and metals for use in surface enhanced Raman spectroscopy.8 SERS was first observed 
on roughened silver electrodes.14 It was initially thought that the roughness caused increased 
Raman signal due to a higher surface area and therefore increased analyte concentration. 
However, it was later discovered that the surface roughness provided the nanoscale surface 
features required for surface plasmon waves to occur.55 Following the discovery of SERS on 
silver electrodes, the SERS spectrum of pyridine on a silver island film was recorded by Chen 
et al., which became a prevalent SERS substrate.56 A silver island film consists of a layer of 
silver several nanometres thick, characterised by a network of nanoscale channels running 




through the silver, giving the appearance of islands, shown schematically in Figure 1.10. These 
gaps between silver islands allow hotspot formation.  
 
Figure 1.10: Schematic diagram of a silver island film 
 
Presently, metal nanospheres are the most common SERS substrate due to their ease of 
synthesis and tunability, allowing the researcher to tailor the size of the particle to their needs 
(Section 1.4.3). It has been suggested that in a spherical particle, the parallel component of the 
plasmon wave is essentially delocalised in all directions, resulting in a more concentrated 
electric field.16,57,58 However, monodisperse spherical nanoparticles do not generally produce 
significant SERS signal without adding an aggregating agent.8 On aggregation, hot spots are 
created at the points where the particles touch in the aggregate clusters.  
Hollow-shell nanoparticles are another popular shape for SERS applications.59,60 Based on the 
core-shell nanoparticles first synthesised by Oldenburg et al. in 1998, which consisted of a gold 
coating or ‘shell’ on the surface of a silica nanoparticle, these hollow structures are fabricated 
by coating a template with metal, and subsequently removing the template.59 The first hollow 
shells were  constructed in 2005 by Liang et al., using cobalt nanoparticles as a template.61 On 
addition of chloroauric acid to the cobalt nanoparticle solution,  Au (III) is reduced to Au (0), 
forming a gold coating on the cobalt nanoparticles. Simultaneously, the Co (0) of the 
nanoparticles is oxidised to Co (II). The result is a hollow gold sphere.32 In more recent years, 
hollow shells have been synthesised from gold-on-silica core-shell particles, where the silica 
core is removed by chemical etching.63,64 These methods have been elaborated to produce more 
exotic shapes, such as multiple-shell nanoparticles or ‘nano-matryoshkas’, hollow nanocubes, 
and nanorattles (Figure 1.11).65–67 Hollow shells of particular interest due to their tunability. 




The SPR resonance of a hollow shell is dependent on its inner diameter and shell thickness; 
both these factors are highly controllable, by synthesising a template of desired diameter, and 
by controlling the amount of coating material added in the shell formation step.63 Hollow-shell 
nanoparticles also give better SERS enhancement than solid nanoparticles, which is thought to 
be due to coupling of the plasmon fields of the two gold surfaces: the inner surface, and the 
outer surface.68  
 
Figure 1.11: Depiction of a hollow gold nanocube, a multiple-shell gold-silica-gold 
nanoparticle, and a gold nanorattle. 
 
Another common shape used for SERS applications are rod-type particles (Figure 1.12), 
synthesised from spherical particles by the seed growth technique.69 The increased signal 
enhancement often observed for these particles, as opposed to spherical particles, is attributed 
to a ‘lightning rod effect’. This effect is observed in nanorods and other structures with atomic 
scale protrusions such as an edge or point on the surface. Indeed, it can be observed in any 
shape with vertices, such as nanotriangles and nanocubes. The curvature of these features 
produces a change in electric potential, therefore giving a large electrical field in the proximity 
of the protrusion.70  
 
Figure 1.12: Summary of some common metal nanoshapes for SERS applications.8 




Nanorods have the additional benefit of having two plasmon resonance bands corresponding 
to the short and long axes. The latter resonance is tuneable in the range of 800-1200 nm. This 
region is often used in SERS experiments on biological material, as there is little fluorescence, 
or absorbance from water and chromophores, allowing for deep light penetration into tissue 
and low background noise (Figure 1.13). Tuning the plasmon resonance of the SERS substrate 
to match the incident laser wavelength can enhance the SERS signal by utilising the surface 
enhanced resonant Raman spectroscopy (SERRS) effect (Section 1.3). 69,71,72 Nanorods are 
therefore ideal for biological SERS applications due to their tunability for absorption in the 
infra-red region.  
 
Figure 1.13: Approximate penetration depth of light into skin (data from Barolet et al.).73 
 
Nanostars (Figure 1.12) are becoming increasingly prevalent, due to the many points on the 
structure giving a large lightening rod factor, which is tuneable by controlling the number of 
points of the nanostar.74 As a general rule, nanoshapes containing more points have a much 
larger signal enhancing factor; for example, Tian et al. have shown that gold nanostars give 
better signal enhancement than nanotriangles, which themselves give slightly better 
enhancement than nanospheres.71 However, research by Yuan et al. suggests that there may be 




an optimal number of points, after which signal enhancement begins to decrease due to 
interference between many hotspots.75 Like nanorods, gold nanostars are also synthesised by 
the seed growth technique, as are many other nanostructures such as prisms and dodecahedra. 
This is a simple technique in which gold nanospheres, synthesised by citrate reduction, can be 
built upon with the aid of a shaping agent. This type of synthesis is shown in Chapter 2. 
In addition to these more common shapes, a large array of colloids with more intricate geometry 
can be found in literature. For example, vapour phase deposition can also be used for complex 




The size of the nanoparticle can have a drastic effect on the Raman signal enhancement.45  It 
is understood that larger particles give a greater SERS effect, due to the increased amount of 
delocalised electrons available which, when excited, produce a stronger electromagnetic field. 
Tian et al. found that silica coated nanoparticles with a 120 nm gold core enhanced Raman 
signals 24 times more than those with a core diameter of 55 nm.76 This is also possibly due to 
the plasmon resonance of the 120 nm particles more closely matching the excitation 
wavelength of 633 nm.71 However, particles with a diameter significantly larger than the 
excitation wavelength often show poor signal enhancement. At this size, higher order non 
radiative modes (multipolar plasmons) are excited more preferentially than dipolar plasmons, 
decreasing Raman signal enhancement.47,77,78  The diameter of the nanoparticle also impacts 
its uptake into the cell; although this is dependent on many other factors such as surface 
coatings, Chithrani et al. have found that of gold nanoparticles up to 100 nm in diameter, 50 
nm particles have the highest uptake efficiency into mammalian cells, so for biological 
applications it could be argued that nanoparticles around this size are the most useful.79 Gold 
nanoparticles above 5 nm are generally regarded as having the same chemical properties as 
bulk gold, and are therefore considered safe for use in biological systems, provided the 
stabilising agent is not harmful.80 
 
1.5 Extrinsic probes  
 
A common technique for the detection of biological materials is the use of extrinsic probes 
(Figure 1.14).81 Unlike intrinsic probes, which rely on the Raman scattering of the analyte 




itself, this technique involves the use of a Raman reporter molecule; a molecule with a large 
Raman cross section immobilised on the metal surface. This layer is often coated with a 
dielectric layer such as a polymer to trap the reporter in place, followed by a final outer coating 
of selective capture molecules to bind the analyte, such as antibodies in the case of biological 
systems. The principle of extrinsic Raman is that when the probe is bound to the analyte, the 
Raman spectrum of the reporter is visible. Extrinsic SERS is not only highly selective, but 
allows the detection of biological systems which would otherwise have many interferents and 
give complex, difficult to interpret spectra. 
 
 
 Figure 1.14: Structure of an extrinsic SERS probe.  
 
1.5.1 Raman Reporters 
 
In order to immobilise the reporter on the substrate surface, the chosen molecule will often 
have an anchoring group; a functional group with a strong affinity for the metal surface.82 
Figure 1.15 shows a number of common anchoring groups used to bind molecules to gold 
surfaces; these groups may also be used for silver substrates due to the similar surface 
chemistry of the two metals.83 





Figure 1.15: Common anchoring groups for gold surface chemistry. 84 
 
Arguably the most popular anchoring group for use with gold substrates is the thiol group. 
Thiols spontaneously form self-assembled monolayers (SAMs) in the presence of gold (0).84 
These ordered monolayers form via the generation of an RS• (thiyl) radical. In the case of other 
sulphur containing anchoring groups such as thioacetate, the mechanism is similar (the acetate 
group is spontaneously cleaved in the presence of gold to yield the thiyl radical) although this 
occurs more slowly than in thiols.85 The strong affinity of the thiol group for gold can be 
rationalised by hard and soft acid and base (HSAB) theory; bulk metals are considered soft 
acids, and are therefore likely to form strong bonds with soft bases such as thiolates.86 The 
tendency of thiols to form such strong S-Au bonds spontaneously makes them the standard for 
gold surface chemistry, and this group is found in many simple Raman reporter molecules.  
 
Amines are less common anchoring groups due to their poorer aurophilicity, though these 
compounds are still known to form self-assembled monolayers on gold surfaces.87 The N-Au 
interaction can be characterised as a weak covalent bond.88 Carboxylic acids are also know to 
form self-assembled monolayers on gold; unlike amines and thiols, these bidentate anchoring 
groups adsorb to the surface via both oxygen atoms when the acid is deprotonated.84 In some 
cases carboxylic acids have been shown to exhibit better ordering on the substrate surface than 
thiols, although their binding strength is weaker.89  
 
The anchoring group can also be removed during the monolayer formation process to yield a 
direct Au-C bond.84 This is the case for diazonium salts, which are typically bound to the metal 
surface by electrochemical grafting.90 In this technique, the diazonium group is 




electrochemically reduced to an aryl radical, which then reacts with the gold surface to form 
an Au-C covalent bond. Although this is a less facile method than the SAM formation of thiols, 
it is an attractive option due to the strong bond formation, as Au-C bonds have been shown to 
be around 0.4 eV stronger than Au-S bonds formed by analogous thiol molecules.  
 
Many SERS systems in the literature utilise simple molecules as reporters, such as 4-
aminothiophenol and 4-mercaptobenzoic acid (Figure 1.16).91–93 These small molecules can be 
synthesised easily or bought commercially, and the process of binding the thiol to the gold 
surface is straightforward. However, their Raman signals can be improved upon, and so 
increasing research has gone towards more complex reporters with specific requirements. 
 
 
Figure 1.16: Structures of 4-aminothiophenol (left) and 4-mercaptobenzoic acid (right). 
 
It is beneficial to match the absorption of the Raman reporter to the excitation wavelength to 
utilise the SERRS effect, as discussed in section 1.3. Therefore, commercially available organic 
dyes with absorption maxima close to the excitation wavelength are commonly used in SERS 
experiments.94 Some common organic dyes used as Raman reporters on gold and silver SERS 
substrates are given in Table 1.2. The dyes can be split into categories defined by their linking 












Binding mode Examples 
Binds electrostatically to metal 
surface 
Crystal violet, rhodamine 6G, rhodamine B, nile 
blue, methylene blue 
Links to surface via S-M interaction Malachite green isothiocyanate, 
tetramethylrhodamine-5-isothiocyanate 
 
Table 2: Examples of commercial dye molecules used as Raman reporters (note: these lists 
are not exhaustive). M= Au, Ag. 94 
 
Despite their weak binding, crystal violet and rhodamine 6G are widely used as Raman 
reporters due to their strong SERRS signals alongside common excitation wavelengths 532 nm 
and 633 nm. 95 Malachite green isothiocyanate has also been used in a range of SERS systems 
due to its strong bond formation with gold and silver substrates, via the isothiocyanate 
group.96,97 These organic dyes are typically used to test novel new SERS substrates, although 
their high fluorescent backgrounds (with the exception of non-fluorescent methylene blue) in 
Raman spectra are a distinct disadvantage.95 
 
 As previously mentioned, red and near-infrared lasers are more popular than visible light for 
SERS experiments involving biological material, as autofluorescence is eliminated, and greater 
depth of penetration into tissue can be achieved (Figure 1.13). Therefore, dyes absorbing red 
and near-infrared light are commonly utilised as SERS reporters. One such dye is Prussian 
blue, an inorganic dye absorbing light in the region between 600-900 nm when bound to gold 
nanoparticles.98,99 Prussian blue gives an intense Raman peak at 2156 cm-1, in the area known 
as the biological silent region. This is the area above 1800 cm-1 (outside of the fingerprint 
region) where there are generally no vibrational modes in biological samples.8,42 Focusing on 
this region avoids interference from the sample, allowing for clearer interpretation.99 Prussian 
blue has been used as a Raman reporter in conjunction with gold nanoparticles for the detection 
of cervical cancer cells (Figure 1.17). The HeLa cervical cancer cell line is known to 
overexpress folic acid receptors; when Prussian blue coated gold nanoparticles were modified 
with folic acid, HeLa cells were selectively detected over the liver cancer cell line HepG2.99 
 





Figure 1.17: Structure of a Prussian blue coated gold nanoparticle.99 
 
In addition to commercially available dyes, there is increasing research into the synthesis of 
novel dyes tailored specifically for SERS experiments. For example, Bedics et al. have 
synthesised chalcogenopyrylium based dyes absorbing in the region of 653-986 nm, making 
them promising for biological SERS applications.100,101,102 One such example is shown in 
Figure 1.18. Furthermore, these dyes have been shown to give SERS signals with an excitation 
wavelength of 1550 nm, which is retina safe; a SERS system using a retina safe laser has 
desirable safety benefits. The dyes also possess thiophene groups, an ideal anchoring group for 
the functionalisation of gold surfaces.  
 
 










1.5.2 Surface coatings 
 
Nanorods and nanostars are often prepared using surfactants such as cetyl trimethylammonium 
bromide (CTAB) as a stabilising agent (Figure 1.19), as the strong repulsion between 
quaternary ammonium groups keeps the nanostructures effectively separated. CTAB can also 
act as a structure directing agent in the synthesis of these structures; in the case of gold 
nanorods, CTAB preferentially binds to side facets of the rods, allowing growth at the ends to 
produce the rod-type shape.103 Although CTAB is generally regarded as safe when bound to a 
metal surface, some studies have shown an increase in toxicity of CTAB coated nanoparticles 
compared to uncoated particles.104 This may be due to the non-covalent nature of CTAB 
binding, allowing it to easily dissociate from the surface, as unbound CTAB is damaging to 
cells.105 In addition, the quaternary ammonium group can cause unwanted interaction with cells 






Figure 1.19: Structure of CTAB (top) and diagram of a CTAB stabilised gold nanorod.103 
 
Silica coated gold nanoparticles (AuNP@SiO2) have been utilised effectively in many extrinsic 
SERS studies.76 Silica surface coatings have been shown to protect the Raman reporter from 
reacting with the surrounding environment, and prevent it from dissociating from the particle 




surface.107,108 This is especially important if the reporter molecule has no anchoring group and 
instead binds to the surface via weak electrostatic forces. Another benefit of a silica shell is 
that it is chemically inert, meaning the particles can be applied to any material without 
chemically bonding to it, which may alter the Raman fingerprint of the material. The presence 
of a silica shell also acts as a spacer, reducing SERS hotspots caused by random aggregation 
of metal nanoparticles, improving the reproducibility of the SERS results.107  These coatings 
are easily prepared using the Stöber method; the base catalysed hydrolysis of tetraethyl 
orthosilicate (TEOS) carried out in water/alcohol mixtures (Figure 1.20). 109–111  Using this 
method, silica coatings as thin as 0.5 nm have been reported, which is desirable as SERS is a 
distance-dependent technique; many groups have reported poor SERS signals for coated gold  
nanoparticles when the shell is thicker than 10 nm.47,112,113  
 
 
Figure 1.20: Simplified reaction Scheme depicting the Stöber process. 114 
 
Gold nanoparticles have also been coated with biocompatible materials such as peptides and 
biopolymers, to aid biocompatibility for SERS studies in biological systems.115 Polyethylene 
glycol (PEG) is frequently used as a gold nanoparticle coating, due to its ability to increase the 
stability of the nanoparticles in biological media. In vitro studies have  shown that PEGylated 
gold nanoparticles have reduced toxicity compared to uncoated nanoparticles, and increased 
cell uptake.116 However, in vivo studies have found that PEG coated particles tend to 




accumulate in the liver significantly more than naked gold nanoparticles, which can cause liver 
damage.117 
 
1.6 SERS probes for medical diagnostics 
 
A previously stated, SERS has been utilised in a number of systems to detect simple molecules 
such as pesticides,6 however its use in medical applications such as diagnostics is still in 
development. The use of SERS as a potential diagnostic technique has drawn interest due to 
the possibility to detect analytes at very low concentrations, with a strong signal.118 The 
following examples have been chosen as they encompass the major types of SERS systems 
used for the detection of disease biomarkers; solution based SERS, and SERS substrates 
immobilised on a surface. 
 
1.6.1 Solution state SERS probes for medical diagnostics 
 
Harmsen et al. have fabricated surface enhanced resonance Raman spectroscopy (SERRS) 
substrates for the detection of various forms of cancer in mice. These substrates are unique due 
to their simple design, consisting of a gold nanostar core, and a Raman reporter trapped on the 
gold surface by a silica shell.  Unlike most extrinsic probes, no component to selectively bind 
the target (such as a peptide or antibody) is incorporated.119 Instead, the nanostars utilise the 
enhanced permeation and retention (EPR) effect. The EPR effect is a phenomenon in which 
nano-scale structures or macromolecules accumulate in cancerous tissue, but not healthy tissue. 
This is thought to be caused by the rapid formation of blood vessels in tumours, leading to gaps 
between endothelial cells, which facilitate the entry of macromolecules into the tumour from 
the bloodstream, as shown in Figure 1.21.120 The molecules or nanostructures used to exploit 
this effect must meet certain requirements, including being above 40 kDa in mass and having 
a weakly negative surface charge.121 The gold nanostars synthesised by Harmsen et al. do meet 
these requirements, allowing several forms of cancer including breast and prostate to be 
detected in mice.   





Figure 1.21: Depiction of the EPR effect 
 
Intrinsic SERS probes have been used for the non-invasive detection of cervical cancer using 
blood plasma.122 Cervical cancer is currently diagnosed following a cervical screening test, 
though studies have shown that attendance at cervical screening appointments has dropped 
amongst young people in recent years, possibly due to the invasive nature of the procedure.123  
The need for a non-invasive diagnostic method is therefore clear. Diagnosis of cervical cancer 
is also currently subjective and reliant on an experienced clinician.124 A study by Feng et al. 
used silver colloids to obtain SERS spectra of blood plasma, identifying significant differences 
in the Raman fingerprints of plasma from cervical cancer patients compared to healthy 
plasma.122 Notably, the spectra indicated higher levels of human serum albumin in the α-helix 
conformation in plasma from cancer patients. This SERS detection system was found to have 
a sensitivity of 96.7 %, although testing on other types of cancer was not carried out, so whether 
this system could differentiate cervical cancer from other types of cancer is uncertain.  
 
The early detection of neurodegenerative conditions (such as Alzheimer’s disease and 
Parkinson’s disease) are also of interest due to the socioeconomic impact of these diseases.125 
Various examples of SERS systems for the detection of dementia biomarkers can be found in 
the literature. Zengin et al. have fabricated SERS sandwich probes for the detection of tau 
proteins, which are present in increased numbers in the cerebral spinal fluid of Alzheimer’s 
patients.126 The SERS substrate used in this system is a classic example of an extrinsic SERS 
probe, consisting of a gold nanoparticle (AuNP) core, a Raman reporter, and an antibody to 
bind the tau proteins. The Raman reporter used is 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), 
a small-molecule type reporter which binds to the gold surface when the disulfate bridge is 
cleaved and the subsequent thiolate molecules form a self-assembled monolayer (SAM). What 




makes this SERS system unique is the addition of iron oxide nanoparticles. These magnetic 
nanoparticles (MNPs) are also functionalised with antibodies, resulting in an MNP-tau-AuNP 
sandwich complex. Because of the magnetic properties of the MNPs, this complex can be 
separated from solution with magnets before SERS analysis, allowing for a clear, easy-to-read 
spectrum without interferents. This method also claims to be significantly faster and more cost-
effective than current tau protein detection methods such as enzyme-linked immunosorbent 
assays (ELISA).126 
 
A similar magnetic SERS ‘sandwich probe’ (Figure 1.22)  has been synthesised by Vohra et 
al. for the diagnosis of squamous cell carcinoma (SCC).127 Diagnosis of this cancer currently 
requires a trained clinician, however, SCC disproportionally effects people from low and 
middle income countries, where resources may be lacking. There is therefore an obvious need 
for a rapid point-of-contact test, requiring minimal training to operate. The aim of the study 
was to develop a SERS system to diagnose SCC by targeting cytokeratin 14 (CK 14), a protein 
expressed in carcinoma cells.128 The SERS substrate consisted of a gold nanorattle core, 
functionalised with a DNA sequence acting as both a reporter and linker to bind CK 14. 
Magnetic nanoparticles were also functionalised with a DNA sequence to target CK 14. These 
sandwich probes successfully detected CK 14 in 93 % of SCC samples and 0 % of non-SCC 
samples, indicating good sensitivity and specificity. 
 
 
Figure 1.22: Simplified depiction of a typical magnetic SERS sandwich complex system. 
 




1.6.2 Substrate Immobilised SERS probes for medical diagnostics 
 
Because SERS is a technique which can only be applied diagnostically if the area of interest 
can be reached by a laser, many diagnostic techniques are focused on creating ‘lab on a chip’ 
systems for blood testing, in which the SERS substrate is immobilized on a surface.129 For 
example, Lee et al. have used microfluidic chips alongside hollow gold nanoparticles for the 
detection of liver cancer. 130 In this system, a surface is functionalised with antibodies capable 
of binding alpha-fetoprotein (AFP), a protein which is present in high levels in hepatocellular 
carcinoma. Hollow gold nanoparticles (HGNs) are also coated with this antibody. The HGN 
solution and a sample containing AFP are then injected into the chip, where the AFP becomes 
immobilised on the antibody-coated surface. The HGNs  bind to the immobilised AFP, creating 
‘sandwich complexes’ on the surface, which can be detected by SERS, depicted in Figure 1.23. 
SERS based lateral flow assays such as these have also shown promising results for the 
detection of many other health conditions, including prostate cancer and HIV.131,132  
 
 
Figure 1.23: Depiction of a typical SERS-based lateral flow experiment. 
 
Pseudomonas aeruginosa is a bacterium which can cause serious infection in people with 
compromised immune systems, with mortality rates of up to 60 %.133 It is particularly 
dangerous to patients suffering chronic lung diseases such as cystic fibrosis, causing increased 
damage to the lungs. To be successfully treated by antibiotics, it is vital that the infection is 
caught early; however, the traditional diagnostic method of bacterial culture can take several 




days, demonstrating the need for a rapid, point-of-care SERS test for the bacterium. Wu et al. 
have used silver nanorods immobilized on glass as SERS substrate for the detection of 
pyocyanin, a toxin secreted by the bacterium. This is an intrinsic SERS system, as a positive 
test result relies on the presence of the biomarker pyocyanin’s Raman fingerprint, rather than 
a reporter molecule. Using this method, pyocyanin can be detected at concentrations as low as 
2.38 x10-8 mol dm-3, which is lower than the average concentration found in sputum samples 
of cystic fibrosis patients who tested positive for pseudomonas aeruginosa. This SERS method 
is therefore promising for the rapid detection of pseudomonas aeruginosa in lung disease 
patients.  
 
A similar intrinsic SERS method was utilised by Premasiri et al., who immobilised gold 
nanoparticles on a silica substrate for the detection of bacteria in urine samples, with the 
intention of using this system for the rapid detection of urinary tract infections.134 This SERS 
system is capable of detecting bacteria concentrations of 105 cfu cm-3, the level required for 
effective diagnosis, with an accuracy greater than 95 % . Furthermore, by obtaining the Raman 
fingerprint of the bacteria, it is possible to identify the exact strain, so that the optimal antibiotic 
treatment can be chosen.  
 
Many SERS systems incorporate closely packed metal nanostructures, as the nano-sized gaps 
between the structures creates a large quantity of SERS hotspots.135 However, biomarkers for 
the detection of diseases are often large molecules such as proteins, which are unable to fit in 
these nanogaps. Thus, research has been carried out to created ‘stretchable’ SERS substrates 
(Figure 1.24), in which the gaps between metal structures can expand and shrink to fit the 
analyte. Mitomo et al. fabricated such a SERS system, in which gold nanoparticles are 
embedded onto a polyacrylic acid gel.136 Results show that when the analyte (the protein 
cytochrome c) is deposited on top of a substrate with closely packed nanostructures, SERS 
signals are small, as the protein cannot fit within the hotspots. However, when the substrate is 
expanded and closed around the protein, SERS signals increase tenfold, making this a 
promising SERS substrate for diagnostic applications. 





Figure 1.24: A ‘stretchable’ SERS substrate for large biomolecules.136 
 
Despite these studies and many others, the use of SERS for biological applications is still a 
relatively new field, requiring a great deal of development. For example, studies on the toxicity 
of gold nanoparticles are few and at times contradictory; adsorption of proteins from biological 
media onto a nanoparticle surface can affect uptake into cells, hence the exact toxicity of a 
SERS substrate ultimately depends on its environment. 137 Currently, gold nanoparticles are 
not approved for human use, and have primarily been used in vitro and in live animal studies.138 
Overall, any probe designed for diagnostic use would require significant testing to ensure safety 
in clinical use and authorisation by the WHO and FDA.139 
 
1.7 Melanoma Skin Cancer Diagnostic Methods: Present and Future 
 
Melanoma skin cancer is currently diagnosed in a two-step procedure; examination by a 
clinician, followed by biopsy.2,140 First, the skin is evaluated by a medical professional. When 
done with the unaided eye, the accuracy of melanoma diagnosis is around 60 %.141 This can be 
improved using dermatoscopy, otherwise known as epiluminescence microscopy.142 A 
dermatoscope is a handheld instrument comprising of a magnifying lens and light source 
(Figure 1.25). Because skin is highly reflective, basic dermatoscopy requires a liquid interface 
between the glass lens and the skin; by eliminating the air interface, reflection from the skin is 
reduced, thus increasing the penetration depth of light into the skin.143  






Figure 1.25: A dermatoscope.144 
 
An alternative technique is polarisation dermatoscopy (Figure 1.26), in which two polarizers 
with perpendicular axis are placed at the light source and detector, respectively.145 Because 
polarized light reflected from the skin maintains its polarization, it is blocked from the detector 
by the second polarizer. However, polarized light which penetrates the skin is scattered in the 
dermis and emerges with random polarization, allowing it to pass through the second polarizer 
into the detector.  This can allow the skin to be inspected in greater detail, revealing features 
beyond the outermost surface which are not otherwise visible. Although dermatoscopy can be 
an effective diagnostic technique, it is ultimately speculative, and the accuracy of diagnosis 
drops significantly when carried out by less experienced clinicians. 141,146 
 





Figure 1.26: Diagram demonstrating how a polarisation dermatoscope uses cross 
polarisation to eliminate reflected light and view deeper into the skin. 
 
If skin cancer is suspected, a biopsy is conducted, in which a small section of tissue is cut from 
the skin (excised) under local anaesthetic and preserved with a fixative. A histopathological 
examination is carried out, wherein the tissue is stained in order to see cellular components 
more clearly, and examined under a microscope.147 This allows for a more detailed view of the 
tissue, but is still ultimately speculative, as well as invasive. In recent years there has been an 
increasing demand for point-of-care diagnostics, which would avoid the need for preserving 
and transporting tissue to a specialist facility, making the process more cost-effective.135 
 
The efficiency of melanoma diagnosis is currently evaluated by the ‘number needed to excise’ 
(NNE), which is defined as the total number of legions excised divided by the number of 
melanomas excised.148 A ten year study involving clinicians in thirteen countries found that 
between 1998 and 2007, the NNE value for melanoma diagnosis in non-specialised clinics did 
not improve at all, and only dropped slightly in specialist clinics, most likely due to the 
introduction of dermatoscopy.142 This illustrates the need for an effective diagnostic technique 
requiring minimal training, making the process of receiving a diagnosis faster and more 
accessible. Furthermore, a non-invasive method would provide a more positive experience for 
the patient, as well as saving time and resources for other patients.  In the following sections, 
examples of research into finding such a method are explored.  




Melanoma tissue is often slightly darker in colour than that of benign lesions, and so many 
diagnostic techniques currently in research are based on the visual appearance of the skin.149 
One such technique is reflectance spectroscopy. Because melanoma tissue is darker, it 
frequently exhibits a lower reflectance value. Several groups have pursued this technique as a 
means of identifying melanoma, though the reflectance of cancerous tissue is often only very 
slightly lower than that of benign tissue, making it difficult to distinguish between the two 
using this method.150,151 This uncertainty is exacerbated by the fact that many of these studies 
use small data sets; although a more comprehensive study by Tomatis et al. used data from 
over a thousand patients, other studies in this field have used as few as six human subjects.152,153  
 
Another technique based on the visual appearance of the skin is machine learning. Using 
photographs of skin lesions, attempts have been made to implement machine learning 
algorithms for the identification of melanoma. However these are often unsuccessful, again 
due to the visual similarity between cancerous and benign growths, as well as poor contrast 
between the growth and surrounding skin.154  
 
There have been some attempts at detecting biomarkers associated with various types of cancer 
using mass spectrometry.155  Using MALDI-TOF-MS, Matharoo-Ball et. al. noted increased 
levels of alpha-1-acid glycoprotein (AAG) in serum samples from patients with stage IV 
melanoma, compared to healthy patients.156 The group noted that this research could be 
expanded to detect melanoma in its earlier stages, however, critics of the method have voiced 
several disadvantages of using mass spectrometry as a diagnostic technique.157 The major 
concerns are poor reproducibility, limited detection sensitivity, and the need for a skilled 
technician to operate the instrument. It should also be noted that several studies have found 
higher AAG levels in patients with various other types of cancer, so this is not necessarily an 
ideal biomarker for melanoma detection.158,159 
 
A number of groups have attempted to identify melanoma by utilising fluorescent properties 
of skin tissue.160 Although many fluorescence-based detection methods rely on the synthesis 
of fluorescent probes, visualising these probes would be difficult due to the autofluorescent 
nature of skin. Therefore, most research in this area is focused on the fluorescent substances 
already in skin, such as melanin, keratin, collagen, NAD(P)H and so on.161 For instance, 
pheomelanin and eumelanin are the melanins responsible for red-yellow and brown-black 
pigmentation, respectively. It has been reported that the ratio of pheomelanin to eumelanin is 




higher in dysplastic nevi (atypical moles which although benign, are at high risk of becoming 
cancerous in future) than in healthy tissue, and higher still in malignant melanoma, resulting in 
red-shifted fluorescence spectra.162  
 
Other studies have focused on the protonated form of nicotinamide adenine dinucleotide 
(NADH) and flavin adenine dinucleotide (FAD) as cancer biomarkers. Healthy cells primarily 
produce energy via mitochondrial oxidative phosphorylation, whereas cancerous cells use 
aerobic glycolysis; this is known as the Warburg effect.163 NADH is a prominent electron 
acceptor in oxidative phosphorylation, and FAD is an electron donor. Therefore, the amounts 
of these molecules present in their bound or unbound states can indicate whether oxidative 
phosphorylation or glycolysis is the dominant process taking place in the cell, thus revealing 
whether the cell in cancerous or healthy.164 Several groups have attempted to use fluorescence 
lifetimes of these biomarkers to distinguish healthy skin cells from melanoma, with no 
success.165,166 However, Pires et al. reported noticeably longer fluorescent lifetimes in the 
melanoma cell line B16F10 as compared to healthy cells, reasoning that FAD in its free form 
has a longer lifetime than protein-bound FAD, and is present in higher amounts when 
glycolysis is the dominant process, indicating the presence of cancer cells. These results have 
not however been repeated in other melanoma cell lines.161 
 
Radioactive labelling has also been pursued as a detection technique.167 The use of melanocyte 
stimulating hormones labelled with 99mTc, 188Re and 111In have been reported for the detection 
of melanoma. Alpha-melanocyte stimulating hormone (α-MSH) is a peptide with a high 
binding affinity for the melanocortin receptor MC1R, which is overexpressed in melanoma. 
Radiolabelled  derivates of this peptide are able to target MC1Rs in order to detect melanoma 
using SPECT/CT (the combination of  single-photon emission computed tomography and 
computerised tomography).167,168 Although these studies in mice have shown better specificity 
for targeting melanoma than other techniques, the overall process is equally as time consuming 
and invasive as a traditional biopsy.  
 
Research has shown that melanoma can be detected by canine olfactory, the process in which 
dogs are trained to detect substances by scent.169 A study by Pickel et al. showed that dogs are 
able to detect melanoma tissue samples planted on healthy patients. Following this, research 
continued to patients with suspected melanoma. The suspected lesions were covered with 
bandages, along with other bandages applied randomly about the patients’ bodies. In six out of 




seven patients, the dogs were able to find the location of the lesion, and biopsies conducted 
several days later confirmed that these lesions were melanoma. In one of these patients, the 
melanoma detected by the dogs was not identified in the initial biopsy and required a second 
biopsy to confirm a diagnosis, indicating that in some cases dogs are able to identify early-
stage melanoma before clinicians. Although promising, this study was small, using only two 
dogs and seven patients, and concerns were raised over whether the dogs actually detected the 
melanoma by scent, or cues by from patients. Furthermore, the training of dogs for olfactory is 
a time consuming and costly process requiring skilled animal handlers.  
 
SERS has excellent potential for use in the diagnosis of melanoma due to its high enhancement 
factors, making it ideal for early stage detection.170–172 However, the main challenge of using 
SERS in this area is acquiring spectra for malignant tissue which is distinct from benign tissue. 
Although some groups, using intrinsic SERS, have identified Raman peaks which are more 
intense in malignant tissue, the intensity of peaks can vary depending on the distribution of 
nanoparticles in the sample, and so reproducibility of this may be uncertain.173–176 Few studies 
have attempted to create extrinsic SERS probes for the selective targeting of melanoma. One 
study successfully detected DNA mutations (BRAF V600E, c-Kit L576P and NRAS Q61K) in 
the plasma of melanoma patients, though these mutations are not present in all melanomas; this 
system may therefore be more useful for informing the treatment of already diagnosed 
melanoma patients, rather than for diagnosis.177 Kumar et al. have created a SERS-based 
microchip for the detection of melanoma chondroitin sulfate proteogly (MCSP), a 
characteristic membrane protein found in melanoma cells.178 However, the system has thus far 
only been tested with ‘simulated’ serum samples (human serum spiked with MCSP), which 
may not be representative of real-life samples. Furthermore, the acquisition of serum from 
blood samples is still an invasive and time-consuming process. Overall, although detection of 
melanoma skin cancer using SERS has been somewhat discussed in the literature, there is scope 
for more research to find an ideal probe. 
 
The purpose of this work is to design and synthesise an extrinsic SERS probe able to selectively 
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2. Surface Enhanced Raman Spectroscopy Probes: Design and 
Initial Testing  
 
A rapid, unspeculative detection system for melanoma detection would allow the disease to be 
caught at an early, treatable stage. SERS is a promising technique for such an application due 
to its low detection limits.1–6 By combining a targeted SERS probe with a table-top Raman 
spectrometer, it could be possible to detect early-stage melanoma at the point-of-care, without 
a specialist present. In the following chapter, the design and synthesis of a SERS probe for the 
detection of melanoma is discussed; first focusing on the synthesis of a basic intrinsic probe, 
followed by the incorporation of Raman reporters. The probe was then functionalised with a 
peptide for targeting the human breast cancer cell line MCF7 for the purposes of testing. 
Functionalisation of the probe to target melanoma is discussed in the following chapter. 
 
2.1 Synthesis of Gold Nanoparticles and Size Dependence  
 
The size of a metal nanoparticle plays a key role in signal enhancement, as a larger particle has 
more free electrons to contribute to a surface plasmon wave, resulting in a greater plasmon 
effect.7 However, it has been reported that when nanoparticles become too large (greater than 
100 nm), signal enhancement ceases to improve and can even diminish.8,9 Before a probe was 
synthesised, the optimal diameter for signal enhancement was explored by synthesising gold 
nanoparticles of various sizes. The signal enhancing properties of these particles were explored 
by comparing their ability to enhance fluorescence.  
 
2.1.1 The Metal Enhanced Fluorescence Effect 
 
Metal enhanced fluorescence is the amplification of fluorescence signals as a result of adding 
plasmonic structures (such as gold nanoparticles) in close proximity to the fluorophore. 10 The 
mechanism by which this occurs is analogous to the SERS effect; the localised electric field at 
the metal surface ELoc (created by coupling of the LSP field to the electric field of incident 
light, Section 1.2) enhances the intensity of fluorescence.11 The metal also enhances 
fluorescence by radiative decay engineering.12 This is a phenomenon in which the presence of 
the metal surface increases the overall radiative decay rate Γ by introducing a new, additional 
radiative decay rate, Γm (Figure 2.1), increasing quantum yield. Much like SERS, metal 




enhanced fluorescence has attracted attention as it facilitates the detection of very small traces 
of analyte, creating the potential for ultra-sensitive fluorescence spectroscopy techniques for 
sensing applications, with minimal cost.13  
 
 
Figure 2.1: Jablonski diagram for a fluorophore without (left) and with (right) metal-
enhancing effects. Em, Γm and km  represent the additional excitation, radiative decay and 
non-radiative decay in the presence of a metal surface, respectively.12 
 
2.1.2 Synthesis of Gold Nanoparticles 
 
Gold nanoparticles of varying sizes were synthesised for these tests. Gold nanoparticles were 
initially chosen for their ease of synthesis compared to more elaborate shapes as well as being 
stable, non-toxic, and efficient supporters of surface plasmons. The nanoparticles were 
synthesised via the Turkevich method, in which sodium chloroaurate is reduced with sodium 
citrate (Scheme 2.1). This is the most frequently used method for gold nanoparticle synthesis 
since it was first developed in 1951.14 The initiation step involves the reduction of Au (III) to 
Au (0) to form gold clusters, which in turn combine to form ‘seed particles’ approximately 1.5 
nm or less in diameter; this seed particle formation is the size determining step of the reaction.15  
 
The citrate in solution causes an increase in pH which shifts the equilibrium of gold species 
from [AuCl4]
- to the less reactive [Au(Cl)4-x(OH)x]
-, which can be understood by considering 
the coupling of equations 2.1 and 2.2.15 The decreased amount of reactive [AuCl4]
- species 
results in the termination of the seed formation step. 
 
[AuCl4]
− + xH2O ⇌ [AuCl4−x(OH)x]− + xH+ + xCl-                       (eq. 2.1)     
 
Cit3− + xH+ ⇌ HxCit(3−x)                                            (eq. 2.2) 




It was initially speculated that the blue colour of the solution after this step is caused by the 
formation of large gold aggregates, which then fragment to form smaller particles. However, 
X-ray scattering data from Wuithschick et. al suggests that the next step actually involves 
[Au(Cl)4-x(OH)x]
- ions becoming attracted into the electric double layer of the seed particles, 
where they are reduced at the particle surface.16  
 
 
Scheme 2.1: Turkevich synthesis of gold nanoparticles using sodium chloroaurate and 
sodium citrate (represented with Θ). 
 
2.1.3 Seed mediated growth and modification 
 
Seed particles were first synthesised by the Turkevich method as described above. A 0.01 w.t.% 
solution of sodium chloroaurate was heated to boiling with sodium citrate until a colour change 
was observed. The seed solution and all subsequent nanoparticle solutions were washed by 
centrifuging at 4400 rpm three times before re-suspending in water. 
In order to reliably synthesise nanoparticles absorbing at specific wavelengths, a controlled 
seed growth method was developed. A seed solution of particles with an absorbance maximum 
of 528 nm, corresponding approximately to a diameter of 9 nm,17 were synthesised, before 
heating to 65 °C with 3 ml sodium citrate (1 w.t.%) and adding 3 mM sodium chloroaurate 
solution dropwise. The UV-Vis spectrum of the reaction mixture was recorded at regular 
intervals until the desired absorbance was achieved (Figure 2.2). 





Figure 2.2: Absorbance of nanoparticles against amount sodium chloroaurate added to 
growth solution. 2 ml sodium citrate was initially added, and a plateau can be seen around 
540 nm; at this point an additional 1 ml citrate was added.  
 
This method was preferable over many of the seed growth methods in the literature, as it does 
not require a strong reducing agent, such as hydroxylamine hydrochloride. Another drawback 
to many methods stated in the literature is that the absorbance of the final product may vary by 
several nanometres, making them unreliable when a specific wavelength is required, as is often 
the case for SERS applications. Although the size distribution of particles synthesised by this 
method is relatively broad, it was the most reliable method of obtaining solutions with a 
specific absorption. This method was primarily used to synthesise particles with an absorbance 
maximum of 548 nm, as these were determined to give the best enhancement of fluorescence 
and Raman signals (as discussed in Section 2.1.4), although a range of particles of varying 
absorbances up to 559 nm were synthesised.  
 
TEM images were used to determine nanoparticle size, as estimating size from the absorption 
maximum, i.e. the plasmon resonance, is not accurate for particles with broad size distribution 
or surface coatings.17 The size distribution of nanoparticles with ʎmax= 548 nm (Figure 2.3) 
was obtained by measuring the diameters of 196 individual nanoparticles with ImageJ software. 
Using this method, the mean diameter was found to be 62 nm with a standard deviation of 26 
nm. The large standard deviation and broad size distribution of the nanoparticles, skewed 
towards smaller diameters, was presumed to be due to the formation of new seeds alongside 




seed growth. The icosahedral geometry of the nanoparticles synthesised by this method may 




Figure 2.3: TEM image of gold nanoparticle (ʎmax = 548 nm), with size distribution. Mean 
particle diameter= 62 nm. 
 
2.1.4 Synthesis of silica coated gold nanoparticles 
 
The nanoparticles were coated in silica, as studies have shown that silica coatings provide 
improved reproducibility in SERS experiments by reducing random hotspots caused by 
aggregation, and eliminating the possibility of varying signals due to different analyte 
interactions with the bare gold surface.18 The silica coating method used was the Stöber method 
(Schemes 2.2-2.3), a hydrolysis of TEOS where silica is deposited on the surface of the gold 
nanoparticles.19,20 TEOS is first undergoes base catalysed hydrolysis to yield SiOH(EtO)3, 
followed by a condensation reaction to give a Si-O-Si containing species. Subsequent 
condensation reactions occur until a SiO2 polymer network with hydroxy and ethoxy terminal 
groups is produced.21,22 A solution of TEOS in ethanol was added to nanoparticles suspended 
in water, adjusted to pH 10 with ammonia.  
 





Scheme 2.2: Hydrolysis and condensation of TEOS to form silica.20  
 
 
Scheme 2.3: Synthesis of silica coated gold nanoparticles 
 
The resulting nanoparticles were centrifuged and suspended in ethanol, as silica coated 
nanoparticles tend to be less stable in water than ethanol, due to the lower zeta potential of 
silica in water.23 Visually, the nanoparticles appeared to be well dispersed, with no aggregate 
visible by eye.  
 
TEM images of the silica coated nanoparticles (Figure 2.4) do not show a visible silica layer, 
although analysis of the samples by EDX indicates that silica is present (Figure 2.5). The 
presence of the silica layer was confirmed by the addition of a linker group. 3-
(Aminopropyl)trimethoxysilane (APTMS) was attached to the silica surface; the terminal 
amine groups of the APTMS were then detectable following the attachment a fluorescent 
marker. This is discussed in greater detail in Section 2.2.1. The fact that the silica coating is 
not visible by TEM, though determined to be present via other methods, may suggest that the 
coating is too thin to observe, though this is not certain, as the few nanoparticles imaged by 
TEM may not be representative of the sample as a whole. However, if the coating is indeed as 
thin as the images suggest, then this is ideal for SERS applications, as the electromagnetic field 
associated with the surface plasmons (responsible for SERS enhancement) decays 
exponentially from the surface.24  














Figure 2.4: TEM images of AuNP@SiO2 nanoparticles. 
 
 
Figure 2.5: EDX spectrum of AuNP@SiO2 nanoparticles. 
 
2.1.5 MEF in solution 
 
To explore the signal enhancing effects of the nanoparticles, the effect of the nanoparticles on 
the fluorescence emission of rhodamine 6G was recorded, both in solution and on gold slides. 




The phenomenon of metal enhanced fluorescence is analogous to surface enhanced Raman 
signals, and therefore is an effective precursory study to show the signal enhancing effects of 
the various nanoparticle solutions. Solutions of 0.1 mM rhodamine 6G were prepared by  
dissolving rhodamine in 10 mg cm-3 solutions of citrate stabilised gold nanoparticles of varying 
λmax values, suspended in water. 
Figure 2.6: Fluorescence spectra of rhodamine 6G in solution with gold nanoparticles of 
varying absorbance maxima. 
 
The results in Figure 2.6 show that generally, as the nanoparticle absorbance maximum 
increases, so does the enhancement of fluorescence emission. The absorption of gold 
nanoparticle solution, indicating the plasmon resonance of the particles, is proportional to 
nanoparticle size.17 It is therefore to be expected that solutions absorbing longer wavelengths, 
indicative of larger particles in solution, give the largest fluorescence enhancement, as plasmon 
enhancing effects are size dependent.25  A maximum enhancement is achieved from the 
nanoparticles with an absorbance of 548 nm, after which there is no further enhancement, 
which is consistent with the generally accepted rule that SERS nanoparticles tend to have an 
optimum size, after which signal enhancement ceases or is diminished.8,9 The reason for the 








2.1.5 MEF on metal surfaces 
 
Solutions of rhodamine 6G and nanoparticles were prepared in the same way, with added 
polyvinyl alcohol (PVA) to form a more viscous liquid. Gold coated glass coverslips were then 
spin coated with the solutions, to create thin layers of rhodamine, with and without gold 
nanoparticles, on a gold surface, and the fluorescence spectra of each of these surfaces was 
measured (Figure 2.7), to determine the effects of a gold film on the fluorescence emission, as 
well as gold nanoparticles. 
 
Figure 2.7: Fluorescence spectra of rhodamine 6G and gold nanoparticle solutions of 
varying absorbances on gold films. 
 
In this thin layer, the low concentration of rhodamine resulted in a less intense fluorescence 
emission peak, and a very sharp prominent peak attributed to the Raman scattering of water, 
which tended to increase as the fluorescence emission decreased. The gold surface enhances 
the Raman peak, which is usually too insignificant to be observed in a fluorescence spectrum. 
As expected, although metal nanoparticles have the ability to enhance fluorescence, metals 
with little or no nanoscale structure do not, and metals in very close contact with fluorophore 
(less than 5 nm) can cause quenching of fluorescence.10 Therefore, although metal 
nanoparticles in solution enhance fluorescence emission, it is quenched when the rhodamine is 
deposited onto a solid gold slide.  




Figure 2.7 also indicates that the signal enhancement diminishes on silica coating, despite TEM 
images suggesting that the coating is thin enough that the LSP wave can penetrate it. The lack 
of signal enhancement may be due to the instability of silica coated particles in solution, which 
experience some aggregation due to the coating causing the particles to ‘stick together’ as 
shown by TEM (Figure 2.4), and a large amount of aggregation may result in a poor distribution 
of the gold particles throughout the film. 
 
It is also possible that the silica layer prevents hotspot formation between the surfaces of the 
gold nanoparticles, resulting in insufficient signal enhancement. Suspending the particles in 
ethanol:water (1:1) helps to prevent aggregation, although this is not ideal for particles to be 
tested in biological systems, as ethanol is toxic to cells. Silica coating may therefore be a more 
appropriate technique for nanostructures which do not require aggregation between particles 
for hotspots formation, such as nanostars as opposed to spheres.  
 
Overall, the results show a strong correlation between signal enhancing effects and nanoparticle 
size, which is consistent with the literature, and therefore the nanoparticles absorbing at 548 
nm were used to synthesise the intrinsic probe described in section 2.2 The results for silica 
coated nanoparticles show little signal enhancement of the Raman peak in the fluorescence 
spectrum, likely because the protective layer prevents hotspot formation between particles. It 
therefore may be ideal to devise a probe which does not rely on aggregation for hotspot 
formation, such as gold nanostars. 
 
2.2 Synthesis of a Surface Enhanced Raman Probe 
 
To begin, a simple intrinsic SERS probe consisting of a gold nanoparticle core and silica 
coating was synthesised, before elaborating on the design by incorporating a reporter, a more 
complex shaped gold core, and a unique cell-surface receptor targeting-peptide for the selective 
detection of various cell lines. 
 
2.2.1 Addition of a Linking Group 
 
The silica coating of the nanoparticles as prepared in section 2.1 allowed the particles to be 
functionalised with (3-aminopropyl)trimethoxysilane (APTMS) as shown in Schemes 2.4-2.5, 




providing a terminal amine group to allow a peptide to be attached, for the selective targeting 
of cell lines. 
 
 
Scheme 2.4: Synthesis of APTMS functionalised gold nanoparticles. 
 
 
Scheme 2.5: Reaction of silica with APTMS 26 
 
To determine success of the reaction, the terminal amine of the APTMS functionalised probe 
coupled with dansyl chloride (Scheme 2.6). Excess danysl chloride was removed by 
centrifuging four times before re-suspending in ethanol. The fluorescence of the nanoparticles 
(Figure 2.8) indicates the presence of dansyl groups on the particle surface, which suggests that 
the functionalisation of the nanoparticles with APTMS to give amine linker groups was 
successful. To further characterise the nanoparticles, the fluorescence was compared to that of 
3-dansylpropyl trimethoxysilane (APTMS-DNS, 1.3 mmol), in order to determine the number 
of linking groups on each particle surface.  
 
 
Scheme 2.6: Synthesis of dansylated nanoparticles. 






Figure 2.8: Fluorescence emission spectra of the intrinsic probe with attached dansyl group, 
as shown in Scheme 2.6, with unbound dansylated trimethoxysilane for comparison. 
 
By comparison of the fluorescence emission and using Beer-Lambert law, the total surface 
concentration of dansylated trimethoxysilane in the nanoparticle solution was calculated to be 
0.16 mM. In a 5.45 x10-8  M solution of gold nanoparticles this gives approximately 2845 
dansyl groups per particle. Assuming all amino groups were dansylated, as an excess of dansyl 
chloride was added, for a solution of nanoparticles with a mean diameter of 62 nm (size 
distribution provided in Figure 2.3) this gives a surface distribution of around one amino 
trimethoxysilane linker group per 5 nm2 of nanoparticle surface. Figure 2.8 also shows an 
emission peak at 684 nm, most likely a 2nd order scattering artifact. 
 
2.2.2 SERS Probe Design 
 
Following the successful fabrication of silica coated gold nanoparticles functionalised with 
APTMS, focus was shifted to create a more complex SERS probe (Figure 2.9), consisting of a 
gold nanostar core, methylene blue Raman reporter, silica coating, and APTMS linker group 
to eventually bind a peptide for the selective detection of a chosen cell line. 






Figure 2.9: Probe design, where ‘MB’ represents the methylene blue reporter. 
 
The new probe design consists again of a gold core, though the shape was changed from a 
nanosphere to a nanostars. It has been established that gold nanostars produce a greater signal 
enhancement that nanoparticles, due to the well-known ‘lightening rod effect’ in which the 
points of the stars effectively act as antennae.27,28 Nanostars also tend to absorb longer 
wavelengths than nanoparticles, absorbing in the visible red region 29,30. This is beneficial as it 
increases the likelihood for resonance Raman enhancement, as the wavelength used for Raman 
experiments was 785 nm.  
 
 The probe also has a Raman reporter, making it ‘extrinsic’; this means that a spectrum of the 
reporter is acquired in experiments, as opposed to the analyte. This system requires the probe 
to specifically bind to the analyte, such that a signal would be observed if the target is present, 
and no signal would be observed if the target was not present (assuming excess probe is rinsed 
away). 31 Extrinsic probes are idea for analysing biological samples, which often have noisy 
spectra due to the many compounds present and can lack favourably strong Raman bands. Over 
the reporter layer, there is a thin silica coating to keep the methylene blue in place and improve 
reproducibility, followed by the addition of linker molecule (3-aminopropyl)trimethoxysilane 
(APTMS), which can then be used to bind a peptide with specific uptake in breast cancer cells. 
A peptide with specificity to breast cancer has been used initially for proof of concept, as this 
cell line was readily available. The system was later altered for the detection of human 
melanoma cells as described in Chapter 3. 
 
2.2.3 Choice of Reporter 
 
It was decided for several reasons that methylene blue (Figure 2.9) would be used as a Raman 
reporter. Most importantly, methylene blue has a λmax value of 665 nm (Figure 2.10). When 
selecting a suitable Raman reporter, the main priority was to find a molecule absorbing close 




to the laser wavelength being used in Raman experiments, in order to utilise the SERRS 
effect.32 The laser used for Raman experiments was 785 nm, both for its ability to penetrate 
several micrometres into the skin, and because autofluorescence of biological tissue is 
negligible at this wavelength. A reporter absorbing in the red region was therefore required.  
 
  
Figure 2.10: UV-Vis spectrum of methylene blue. Spectral data was acquired from 
Fluorophores.org. 
 
Although it would be possible to find molecules with a λmax value closer to 785 nm, there are 
other benefits to using methylene blue: it is a non-fluorescent dye, minimising background 
noise in Raman spectral acquisition; it gives strong Raman signals which allow the probe to be 
easily identified in spectra; and it has been FDA approved for medical use.33 Methylene blue 
has also been shown to bind to gold surfaces via electrostatic interactions,34 meaning it can be 
deposited directly onto the surface of the gold without any further modifications to the 
molecule. Granted, methylene blue does not adhere to the surface as strongly as a covalently 
bonded reporter would, however this issue can be overcome by applying a silica coating to the 








2.2.4 Gold nanostar synthesis  
 
 
Gold nanostar (AuNS) synthesis is typically a two-step process in which ‘seed particles’ (gold 
nanoparticles around 5 nm in diameter) are synthesised using a sodium chloroaurate or 
chloroauric acid, and a reducing agent. A structure directing agent such as silver nitrate is then 
reduced in situ and silver is deposited on {110} facets of the gold surface, before further 
choroaurate is added to build up the gold ‘points’ of the stars on top of these silver deposits 
(Scheme 2.7 a).35  
 
Scheme 2.7: Two methods for gold nanostar synthesis. A, the most common 'two step' method, 
using pre-made gold seed particles; and  B, a 'one pot' method. 
 
Other groups such as Kedia et al. have reported one pot methods, in which a single reagent 
such as polyvinylpyrrolidone (PVP) can act as a reducing agent for seed formation, a structure 
directing agent for point growth, and a stabilising agent (Scheme 2.7 b).36 There are numerous 
theories as to the mechanism for reduction of chloroaurate by PVP. Several groups suggest that 
Au3+ forms a weak coordination complex with an enolate form of PVP, and this unstable 
complex (the exact structure of which is disputed) rearranges to give Au(0) and pyrrolidone in 
its amide form, or chlorinated PVP byproducts.36–39 On the other hand, Hoppe et al. proposes 
two mechanisms involving radicals (Scheme 2.8), in which either the metal ion directly 




abstracts a hydrogen atom from PVP to form an organic radical (which can then react further 
with the metal ion) or PVP degrades in the presence of the metal to form an organic radical.40 
 
Scheme 2.8: Proposed mechanisms for the reduction of gold by PVP via radical 
intermediates. 
 
 PVP acts as a structure directing agent by binding selectively to Au{100} facets, preventing 
Au(0) deposits from building up in those areas.36 PVP is also a good stabilising agent due to 
its hydrophobic carbon chains, which extend into the solvent and repel one another, thus 
stabilising the particles with steric hindrance.41 The ‘two-step’ and ‘one-pot’ methods for gold 
nanostar synthesis from the literature (Schemes 2.7 a and b) were compared and adapted. 
 
By comparing TEM images (Figure 2.11), it is clear that the two-step-method creates stars with 
more defined points, which have the potential for good signal enhancement. However, these 
points are not symmetrical or homogenous in length, and uniformity is preferred to ensure 
repeatable signal enhancement results. The one pot method on the other hand produced 
nanostars with many points roughly equal in length, although these points were not long or 
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Figure 2.11: Top: gold nanostars made by the two-step method, without (left) and with 
(right) silica coating. Bottom: Gold nanostars made by the one pot method, without (left) and 
with (right) silica coating 
 
Methylene blue and silica were applied to both nanostar batches, as shown in Scheme 2.9. 
These products are referred to as AuNS-MB@SiO2, with MB denoting methylene blue and 
@SiO2 denoting the silica coating. 
 
Scheme 2.9: Synthesis of AuNS-MB@SiO2 
 
Raman spectra (Figures 2.12-2.13) showed that the methylene blue peaks were significantly 
more enhanced, with less noise, using stars made by the one-pot method, as opposed to the 
two-step method. The most likely explanation for this is the thickness of the silica coating. 
Because the two-step-method produced stars with fewer points, the spaces between these points 
became clogged with silica in the coating process, as shown by TEM in Figure 2.11. The 




thickness of this coating most likely caused the reduction in Raman enhancement, as the SERS 
effect is distance-dependent.  The one-pot method produced stars with more closely packed 
points; since the surface of these stars has fewer large troughs where silica build-up can occur, 
a much thinner more even coating was achieved. Considering all of this, the one-pot method 
was used for all syntheses going forward. These stars have an average point-to-point diameter 
of 55 nm, confirmed by TEM, and star-point plasmon resonance of 975 nm (Figure 2.14). 
 
Figure 2.12: Raman spectrum of the SERS probe made by the one pot method, overlayed with 
the spectrum of the Raman reporter methylene blue (MB). 





Figure 2.13: Raman spectrum of the SERS probe AuNS-MB@SiO2 made by the two-step 
method, overlayed with the spectrum of the Raman reporter methylene blue (MB). 
 
 
Figure 2.14: Size distribution (left)  and UV-Vis spectrum (right) of gold nanostars. λmax 
indicates plasmon resonance of the star points, while the broader peak across much of the 
spectrum indicates the plasmon resonance of the star core. The broadness of the peak can be 
attributed to the amorphous shape of the stars. 
 




2.2.5 Probe Synthesis: Silica Coating Optimisation 
 
The silica coating method, as used in previous synthesis, was adapted to produce the thinnest 
possible layer. The initial method of silica coating involved stirring the nanostars in a solution 
of TEOS for 16 hours, according to literature, and is the same method used in Section 2.1 for 
the coating of gold nanoparticles.42 In contrast to particles, using this method with stars resulted 
in a thick coating, likely due to silica build-up between the points of the stars. This excess silica 
causes particles to stick together (Figure 2.15).  
 
 
Figure 2.15: Left: silica coated nanostars before optimisation. An outline can be seen around 
the particles indicating a thicker coating, and the particles can also be seen sticking together 
in a ‘clump’. Right: silica coated nanostars after optimisation. 
 
Although this aggregation can cause increased SERS hotspots, the disordered nature of the 
aggregation makes signal enhancement too variable, and therefore is best avoided. An alternate 
coating method as described for use with gold nanoparticles by Li et al. was attempted, in 
which silica coating is carried out using (3-aminopropyl)trimethoxysilane (APTMS) and 
sodium silicate solution as opposed to tetraethyl orthosilicate (TEOS),18 however this did not 
yield any coating and so it was decided instead that the best course of action would be to 
optimise the TEOS method. It was found that reducing the TEOS concentration any more 
resulted in no reaction occurring, so instead shorter stirring times were used. It was found that 
the reaction still took place after reducing stirring time from overnight to one hour, and a much 




thinner coating was produced (Figure 2.15, right). This resulted in enhanced signals of the 
methylene blue Raman reporter, and less noise (Figure 2.16).  
 
Figure 2.16: Raman spectra of the probe before and after optimising the silica coating 
method, with the spectrum of the methylene blue Raman reporter overlaid (MB). 
 
 
The coating is not obvious via TEM at this resolution, however it is assumed to be present as 
it was possible to attach and observe the APTMS linker group, which bonds to the silica coating 
(Section 2.2.6). Silicone and oxygen are also observed in the EDX spectrum (Figure 2.17). 
 





Figure 2.17: EDX spectrum of AuNS-MB@SiO2 
 
2.2.6 Linker Group Attachment 
 
APTMS could be added immediately after the silica coating step, meaning that silica coating 
and linker addition could be carried out as a one-pot reaction (with reagents added 
sequentially). The ease of this optimised synthetic route, and its reduced reaction time, would 
greatly simplify the process of producing the probe commercially, if the final product reaches 
this stage.  
 
 
Scheme 2.10: APTMS functionalisation of AuNS-MB@SiO2 
 
The number of linker groups on the surface was determined by addition of a fluorescent 
dansylate group (Scheme 2.11) and calculating the moles of fluorescent species via Beer-
Lambert Law (see Figure 2.18 for fluorescence spectra). By this method, it was determined 
that two in every three probes has a linker group, although results may be inaccurate due to 
surface enhanced fluorescence of the dansylate group caused by the nanostars. Failure to attach 
APTMS to some nanostars may be due to aggregation, making the star surface inaccessible.  
 
 










Figure 2.18: Fluorescence spectrum of the dansylated SERS probe with the fluorescence 
spectrum of dansylated APTMS solution on its own. 
 




2.2.7 Specificity for MCF7 
 
The APTMS linker group, with a terminal amine, allowed a peptide to be attached for specific 
binding to the human breast cancer cell line MCF7 (Scheme 2.12). This cell line was used for 
initial testing as it was readily available; the probe was later modified for melanoma targeting 
(Chapter 3). The peptide chosen was the chain DMPGTVLP (Figure 2.19), purchased from 
Biopeptek Ltd. This peptide has been utilised in numerous studies for targeting MCF7.44 
Studies by Bedi et al. show that this peptide binds to the surface of MCF7 cells, and that binding 
of a drug delivery vessel with this peptide incorporated into its structure was 2000 times higher 
than that of a non-specific vessel.43 The effectiveness of this DMPGTVLP for creating a 
selective SERS probe to target MCF7 is explored in Section 2.4. 
 
  














2.3 Probe Characterisation 
 
2.3.1 Limit of Detection 
 
Raman spectra were acquired for the probe at varying concentrations, and the intensity of a 
prominent methylene blue peak at 512 cm-1 was plotted for each, showing a linear relationship 
between intensity and probe concentration (Figure 2.20). The limit of detection of the probe 
(the lowest theoretical concentration at which it is possible to detect the reporter, with the 
Raman instrumentation used in this report) was calculated using this linear relationship45 and 
found to be 0.0025 mg ml-1. Only three repetitions were used for this experiment, and a greater 
number would be required for more in-depth analysis.  
 
Figure 2.20: Plot of probe concentration against peak intensity of the methylene blue Raman 




To determine the toxicity of the probe, measurements were carried out as described in the 
experimental section. Toxicity experiments were carried out with all cell lines used in this 
work; MCF7 (chemotherapeutically resistant human breast cancer) for which the probe was 
initially designed, A375 (human melanoma cells) which the probe was later modified to target 




(Chapter 3), and NIH 3T3 (mouse skin fibroblasts cells) which are used throughout as a control 
cell line. Results in Figures 2.21-2.23 show that the probe is non-toxic at working 
concentrations (concentrations of 0.5 mg ml-1 are applied to samples for SERS experiments), 
as there is no visible drop in cell viability with increasing probe concentration.  
 
 
Figure 2.21: Plot of probe concentration against cell viability for MCF7. Error bars 
represent standard error 
 
 
Figure 2.22: Plot of probe concentration against cell viability for NIH 3T3. Error bars 
represent standard error 









2.4 SERS Studies 
 
Surface enhanced Raman experiments were carried out with MCF7 and NIH 3T3 cell lines to 
determine the selectivity of the probe for MCF7. The probe was applied to cell samples, and a 
Raman spectrum was acquired, before rinsing thoroughly with deionised water. A spectrum 
was then acquired again, to determine whether the probe would ‘rinse off’ non-target NIH 3T3 
cells and bind selectively to MCF7. The experiments were also repeated using a ‘control 
probe’, i.e. a probe without an attached peptide, to determine whether the peptide was 
responsible for selective binding. Spectra are shown in Figures 2.24-2.27. Negative Raman 
intensities are a result of baseline correction carried out using MATLAB.  





Figure 2.24: Raman spectra of NIH 3T3 cells with non-selective control probe, before and 
after rinsing. 
 
            
Figure 2.25: Raman spectra of NIH 3T3 cells with probe, before and after rinsing. 





Figure 2.26: Raman spectra of MCF7 cells with probe, before and after rinsing. 
 
Figure 2.27: Raman spectra of MCF7 cells with non-selective control probe, before and after 
rinsing. 




Figures 2.24-2.25 show that the probe (both the selective probe and the unselective control) 
does indeed rinse out of NIH 3T3 cells, as a distinct drop in signal is observed. Signal loss is 
also observed when the dosed MCF7 cells are rinsed (Figure 2.26), though not as much as in 
NIH 3T3, particularly in the region 400-1000 cm-1. This suggests that probe does bind 
selectively to MCF7. Signal loss is also observed when MCF7 cell samples containing the non-
selective control probe are rinsed (Figure 2.27), however a significant amount of signal 
remains, suggesting that not all of the probes have been removed on rinsing.  
The residual amounts of probe in NIH 3T3 after rinsing, as well as the residual control probe 
in MCF7 after rinsing, could be attributed to the EPR effect. These experiments are also flawed 
as it is not possible to rinse the cells vigorously enough to remove all residual probe, without 
rinsing the cells themselves off the slides, which may also be the reason that signal is not 
completely lost from NIH 3T3, or from MCF7 with the control probe, upon rinsing. However, 
it is clear that SERS signals after rinsing are much less diminished in MCF7 with the selective 
probe, suggesting that the peptide does contribute to selectivity. Because removal of all traces 
of unbound probe may not be possible with rinsing, a ‘minimum signal height’ must be decided 
upon for clinical use, in order for an operator to confirm selective probe binding, based on peak 
intensity. 
 
2.5 Confocal Microscopy  
 
To further evaluate the specificity of the probe, laser scanning confocal microscopy (LSCM) 
was carried out with MCF7, using NIH-3T3 cells as a control. As an additional control, the 
probe was also tested with and without the MCF7 specific peptide. Because the probe is non-
fluorescent, the structure needed to be modified to make it visible by LSCM, which usually 
requires samples to be stained with a fluorophore. The methylene blue reporter was therefore 
replaced with cresyl violet (Figure 2.28), a structurally similar but fluorescent dye. This 
fluorescent probe was again made with and without the MCF7 specific peptide; these analogues 
will be referred to as ‘CV-probe’ and ‘CV- control probe’ respectively.  
 
Figure 2.28: Structure of cresyl violet fluorescent dye. 




The CV-control probe, without peptide, goes into both MCF7 and NIH 3T3 cells 
indiscriminately (Figure 2.29). A likely reason for this is that the silica coating, which is highly 
hydrophilic, is readily taken up by both cell lines. It is of course preferable that the CV-control 
probe would not go into the cells at all, so it can be assured that the probe will only give a 
signal when it is bound to the target cells via the selective peptide. One way to work around 
this could be to implement a hydrophobic coating. Alternatively, if methylene blue was 
replaced with an alternative reporter, binding more strongly to the surface, the need for a 
protective polymer coating may be all together redundant.  
 
Figure 2.29: LSCM images of MCF7 (left) and NIH 3T3 (right) cells with the cresyl violet 
non-specific control probe, overlaid with bright field transmission light microscopy images. 
Transmission λex 488nm; fluorescence λex 633 nm, λem 650-800 nm. Uptake of the probe is 
evident from the red emission seen inside the cells.  Scale bar 20 μm. Spots in the background 
are caused by the silica coated probe adhering to the glass coverslip. 
 
The CV probe with the peptide attached is taken up into MCF7, as can be seen in Figure 2.30. 
In contrast, no uptake is observed with NIH 3T3. The reduced uptake into NIH 3T3 with the 
peptide-functionalised probe compared to the control probe is possibly caused by the peptide 
allowing the probe to be coated with proteins from the cell media, making it too large to be 
taken up by the cell. Despite this effect, the probe still has a greater affinity for the MCF7 cells 
due to the selective targeting peptide.  
 





Figure 2.30: LSCM images of MCF7 (left) and NIH 3T3 (right) cells with the cresyl violet 
MCF7-specific probe overlaid with bright field transmission light microscopy images. 
Transmission λex 488nm; fluorescence λex 633 nm, λem 650-800 nm. In MCF7, uptake of the 
probe is evident from the red emission seen inside the cells; scale bar 10 μm. In NIH 3T3, no 
such uptake is observed; scale bar 20 μm. 
 
2.6 Alternative Reporter Molecules 
 
One of the challenges of designing an extrinsic SERS probe is finding a suitable Raman 
reporter. The main factors explored in most cases are the signal enhancing effects of the 
reporter, and whether it produces a strong, clear Raman signal. However, there is less emphasis 
on ease of synthesis, and cost. Following the success of the methylene blue reporter, the use of 
other commercially available red and near-infra red absorbing dyes were explored, as an 
economical alternative to current Raman reporters in the literature.  
 
 
2.6.1 Comparison of Dyes 
 
When choosing a reporter, it is desirable to have a molecule which absorbs close to the laser 
wavelength being used in Raman experiments, in order to utilise the SERRS effect. The laser 
wavelength used for experiments in this section is 785 nm, chosen for its ability to penetrate 
into tissue, and because it eliminates noise cause by the autofluorescence of biological material 
often observed with shorter wavelengths.  




As an alternative to novel, custom-made reporters, which can be difficult and costly to 
synthesise, commercial dyes were tested as Raman reporters.46–49 Several commercial dyes 
were incorporated into extrinsic probes and tested as an alternative to bespoke reporters.  The 
structures and absorbance of four commercial near infra-red (NIR) dyes:  HITCI, Styryl 9, and 





Figure 2.31: Structure and UV-Vis spectrum of HITCI in ethanol. Spectrum acquired by Dr 
Robert Pal. 
 


























Figure 2.33: Structure and UV-Vis spectrum of Rhodamine 800 in ethanol. 








Figure 2.34: Structure and UV-Vis spectrum of IR 806 in chloroform. Spectral data was 
obtained from Fluorophores.org. 
 
As can be seen by the UV-Vis spectra in Figures 2.31-2.34, all three dyes have some 
absorbance at 785 nm, which is ideal for resonance Raman effects.  It is not necessary for the 
absorbance maximum to match 785 nm exactly; this may in fact cause a great deal of 
interference due to the florescence of the reporter.  
 












Table 2.1: Raman spectra of HITCI (A), Styryl 9 (B), Rhodamine 800 (C) and IR806 (D). 
 
The Raman spectra of all four dyes were recorded as shown in Table 2.1. The spectra of IR 806 
and rhodamine 800 do not have significant strong peaks, and although the spectrum of styryl 9 
has some notable peaks, these are noisy and lack definition.  These dyes were therefore not 
taken any further. HITCI however showed strong peaks at 506 and 558 cm-1, as well as some 
defined peaks at 797 and 933 cm-1, making it potentially an ideal reporter. A probe was 
therefore synthesised with HITCI as the reporter (Scheme 2.13). As with the previous probe 




using methylene blue, this was modified to be made selective with MCF7 cells and initially 
tested with this cell line.  
 
Scheme 2.13: Synthesis of AuNS-HITCI@SiO2-APTMS-DMPGTVLP 
 
2.7 Alternative Probe Characterisation   
 
 
2.7.1 Limit of Detection 
The limit of detection of the HITCI reporter probe was investigated. The intensity of a 
prominent peak in the Raman spectrum of HITCI, 503 cm-1, was recorded at varying 
concentrations (Figure 2.35). The signal intensity is seen to increase with increasing 
concentration, though the exact relationship cannot be said to be linear due to the amount of 
error, as shown by the standard error bars on the graph below. This large difference in 
measurements at a given concentration, resulting in a large error, is likely caused by 
aggregation. Aggregation of the sample will lead to large clusters of the probe in certain areas 
of the sample, with very few individual probes between these clusters. Following from this, it 
is logical that some spectra would have amplified signals, due to the Raman hotspots of the 
aggregate cluster, and some spectra would have weak signals, due to large areas of sample with 
little probe at all. This lack of stability is a stark contrast to the methylene blue probe, which 
appeared stable in solution to the eye (the solution remained a deep blue, suggesting an evenly 




dispersed colloid, and the probe was not seen to ‘crash out’ of solution and collect at the bottom 
of the sample bottle) for around one month; much longer than the HITCI probe which would 
show visible signs of aggregation after around 3 days. This is also reflected in the limit of 
detection study of the methylene blue probe, as the margin of error is much lower. The reason 
for this disparity in stability is unclear.  
 
Figure 2.35: Limit of detection study of AuNS-HITCI@SiO2, showing probe concentration 
against the intensity of a prominent peak at 503 cm-1 the Raman spectrum of HITCI . Error 
bars represent standard error, which is large due to instability of the probe in solution. 
 
2.7.2 Toxicity  
Dosing relevant cell lines (MCF7, NIH 3T3 and A375) for 24 hours showed no clear correlation 
between cell viability and probe concentration, as can be seen in Figures 2.36-2.38 below, so 
it can be said that AuNS-HITCI@SiO2 is non-toxic at working concentrations. 









Figure 2.37: Plot of probe concentration vs cell viability for NIH 3T3. Error bars represent 
standard error 
 





Figure 2.38: Plot of probe concentration vs cell viability for A375. Error bars represent 
standard error 
 
2.7.3 SERS Studies  
Surface enhanced Raman experiments were carried out using the peptide modified HITCI 
probe in order to determine its selectivity for the MCF7 cell line. After these preliminary tests, 
the probe could be modified for the A375 skin cancer cell line, as described in Chapter 3. Two 
different controls were used in these experiments. First, a control cell line, NIH 3T3, was 
compared with MCF7 to determine selectivity for MCF7. The experiment was also repeated 
with and without the peptide DMPGTVLP to determine that it was this component of the probe 
affecting selectivity. The term ‘control probe’ is used to refer to the probe without the selective 
peptide attached. Results are displayed and discussed below. Experimental set-up is detailed in 
Chapter 6. Negative Raman intensities are a result of baseline correction carried out using 
MATLAB. 
 





Figure 2.39: SERS spectra of NIH 3T3 cell pellets with AuNS-HITCI@SiO2, without peptide 
 
Figure 2.40: SERS spectra of NIH 3T3 cell pellets with AuNS-HITCI@SiO2-DMPGTVLP 





Figure 2.41: SERS spectra of MCF7 cell pellets with AuNS-HITCI@SiO2 
 
Figure 2.42: SERS spectra of MCF7 cell pellets with AuNS-HITCI@SiO2-DMPGTVLP 




Figure 2.39 shows the spectrum of the control probe dosed onto NIH 3T3. As expected, when 
the probe is rinsed from the cells, the signal of the HITCI reporter disappears, as there is no 
peptide to target the cells and bind the probe to them. The NIH 3T3 cells were then dosed with 
AuNS-HITCI@SiO2-DMPGTVLP, the peptide functionalised probe, which again rinsed from 
the probe (Figure 2.40). Both of these experiments were repeated with the MCF7 cell line. 
However, the selective probe containing the MCF7 targeting peptide failed to remain in the 
cells after rinsing (Figure 2.42). Since this peptide successfully targeted MCF7 cells in previous 
experiments with the methylene blue reporter, the reason for this is likely due to the poor 
stability of the probe, which showed visible signs of aggregation (the solution was a less deep 
shade of blue with some aggregate visible by eye). A small amount of aggregation can cause 
increased SERS signals due to hotspot formation, as discussed previously. However, too much 
aggregation causes the probe to accumulate in large, widely separated clusters, making the 
concentration of the probe in solution effectively much lower.  It is therefore likely that the 
probe was not sufficiently spread throughout the cell sample to give a SERS signal. Overall, 
the results suggest that the HITCI probe is not suitably reliable, due to poor stability.   
The purpose of the work herein was to construct the foundations of a SERS probe to be later 
modified for selective melanoma detection. Each aspect of the probe; core material, shape, 
coating, and reporter, has been selected to optimise signal enhancement, biocompatibility, 
stability, and ease of synthesis. Finding a suitable NIR dye for use as a Raman reporter was of 
particular interest. Often, NIR reporters presented in the literature are novel molecules 
requiring multi-step synthesis, which can be costly and time-consuming.47,48,50,51 Commercial 
dyes are regularly utilised as SERS reporters due to their availability; however, these dyes do 
not typically absorb in the NIR region, and are thus unable to fully utilise the SERRS effect 
when used alongside a NIR laser.51-52 Of the red and NIR absorbing dyes explored in this work, 
it can be concluded that the methylene blue was the most successful Raman reporter, giving a 
clear signal which was present when bound to MCF7 target cells via the selective peptide, but 
rinsing away to give diminished signal when it was unable to selectively bind a target. HITCI, 
though giving promising Raman signals, was unstable when incorporated into a probe. Moving 
forward, the suitability of the methylene blue probe to detect human melanoma is explored in 
the following chapter. 
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3. Selective Targeting of Human Melanoma 
 
Skin cancer is the 5th most common cancer in the UK, and appears to be rising.1 It  can be 
divided into two categories: melanoma, arising from melanocytes (melanin producing cells in 
the epidermis) and carcinoma, arising from basal and squamous cells (also found in the 
epidermis).2,3 Of these two types, melanoma accounts for the vast majority of skin cancer 
deaths, being significantly less treatable than carninoma.4 Skin cancer deaths have risen 
dramatically in recent years, increasing 149 % since the early 1970s. As with all types of 
cancer, the key to treatment is to detect the cancer as early as possible. In the case of melanoma, 
by the time the melanoma has grown to a thickness of over 4 mm, the probability of five-year 
survival drops from around 70 % to 45 %,  so the need for early detection is clear.5 However, 
current diagnostic methods for melanoma skin cancer could do with improvement. In the first 
instance, the melanoma is examined by eye; the human error associated with this method is 
obvious. If melanoma is suspected, the patient will then be sent for a biopsy, an invasive and 
time consuming procedure.6  
In this project, it is proposed that melanoma skin cancer could be detected using SERS, in a 
method which would involve applying a SERS probe to the skin, rinsing the area with water to 
remove any probe which has not selectively bound to the target, and analysing this area with a 
Table-top, eye-safe Raman spectrometer. In theory, if melanoma is present, a SERS signal 
would be observed. This method would make melanoma detection fast, taking mere minutes, 
non-invasive, and would give a definitive diagnosis without human error. Furthermore, this 
method negates the need for a specialist, as it would require minimal training and could be 
carried out by any member of staff. A schematic demonstrating the concept is given in Figure 
3.1. 





Figure 3.1: Concept of SERS diagnostic system for melanoma. 
 
In previous chapters, the development of a SERS probe for melanoma detection has been 
discussed, although the key aspect of the probe has not yet been addressed; a peptide to 
selectively bind the SERS probe to its target, malignant melanoma cells. In this section, a 
method for targeting malignant melanoma is discussed. 
 
3.1 Identifying an appropriate peptide 
 
Most of the research into melanoma detection is focused on utilising melanocortin receptors. 
Melanocortin receptors are a family of G-protein coupled receptors (GPCRs), activated by 
melanocortins (peptide hormones). The known members of this group are MC1R, MC2R, 
MC3R, MC4R, and MC5R. The group as a whole are responsible for numerous processes such 
as appetite control and immune function.7–9 Sometimes known as melanocyte-stimulating 
hormone receptor (MSHR), MC1R is one of the main proteins involved in controlling skin and 
hair pigmentation, and is therefore of key interest in skin cancer research. Studies have shown 
that MC1R is overexpressed in melanoma, compared to healthy skin cells.10–14 Therefore, a 




probe which is able to detect unusually high levels of MC1R could indicate the presence of 
skin cancer.  
 
Numerous studies have been conducted to find peptides which target MC1R effectively; the 
majority of these peptides are, logically, derived from melanocortins; in particular, melanocyte 
stimulating hormones (MSHs). This family of hormones consists of α-MSH, β-MSH and γ-
MSH, although α-MSH (Figure 3.2) is the most prevalent MSH being utilised in this area, due 
to its superior affinity for MC1Rs.15 α-MSH consists of the following sequence: Ac-Ser-Tyr-
Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2.
16 The critical ‘messenger sequence’ of 
this peptide is His-Phe-Arg-Trp. This is the minimum fragment required to stimulate a response 
from MC1Rs; the other amino acids can be substituted to varying effects.17,18  
 
 
Figure 3.2: Structure of α-MSH with messenger sequence highlighted. 
 
One of the most widely researched derivatives of this peptide is [Nleu4-D-Phe7]α-MSH, also 
known as NPD-MSH (Figure 3.3). This peptide incorporates norleucine, an isomer of leucine, 
at position four in the peptide chain, in place of methionine. At position seven phenylaniline is 
replaced by its stereoisomer D-phenylaniline. NPD-MSH was first synthesised by Sawyer et. 
al in 1980, who noted its improved stability in biological media compared to unmodified α-
MSH.19 Most notably, NPD-MSH has been found to bind to MC1Rs more effectively, in some 
cases exhibiting a potency up to twenty six times greater than α-MSH.19–21 Binding of NPD-
MSH and unmodified α-MSH to MC1R receptors is shown in Figure 3.4. 
 



























Figure 3.4: Schematic diagram showing binding of the messenger sequence of α-MSH and 
NPD-MSH to hydrophobic (red) and ionic (blue) binding pockets in MC1R.20 
 
NDP-MSH is the gold standard for MC1R targeting; although some groups have modified it, 
few have sought a different structure all together.22–25 One of the major reasons for modification 
of NDP-MSH is its tendency to accumulate in the liver and kidneys.26,27 However, if used 
topically, this would not occur and is therefore not a concern for a skin cancer detection system 
applied directly to the skin surface. Going forward, the probe synthesised in Chapter 2, using  




methylene blue as a Raman reporter, was modified to incorporate the peptide NDP-MSH for 
targeting skin cancer cells.  
 
It was also necessary to identify an appropriate cell line for targeting. There are a number of 
human melanoma cell lines available commercially, all expressing differing amounts of 
MC1Rs. The human melanoma cell line A375 is widely used in skin cancer research and has 
been confirmed by several groups to express MC1Rs, making it an appropriate cell line for this 
work.28–30 
 
3.2 Peptide coupling to SERS probes 
 
In Chapter 2, the basis of a SERS probe was synthesised, incorporating a gold nanostar core, 
methylene blue Raman reporter, a silica shell to ‘trap’ the reporter in place, and an APTMS 
linker group to bind a selective peptide. Following initial tests with the human breast cancer 
line MCF7 using the peptide DMPGTVLP, which proved successful, peptide coupling was 
carried out with NDP-MSH, in order to test the probe with the cell line A375. Peptide coupling 
between the SERS probe and NDP-MSH was carried out using the same method as the previous 
peptide coupling, with dicyclohexylmethanediimine (DCC) as a coupling agent (Scheme 3.1). 
 
 
Scheme 3.1: Peptide coupling of NDP-MSH to the linker group of the SERS probe 
 
3.3 Toxicity of the final probe 
 
Toxicity of the control probe AuNS-MB@SiO2 was tested with various cell lines in Chapter 2. 
These measurements were repeated for the final selective probe AuNS-MB@SiO2-NDPMSH 




with the human melanoma cell line A375 to ensure the presence of the peptide did not affect 
toxicity. Cell were dosed with the probe for 24 hours as described in Chapter 6. 
 
Figure 3.5: Plot of selective probe AuNS-MB@SiO2-NDPMSH concentration against cell 
viability for A375. Error bars represent standard error. 
 
Figure 3.5 shows the dose-response data for AuNS-MB@SiO2-NDPMSH with the A375 cell 
line. Due to some variation in the quality of live-cell samples, several error bars are large; the 
slight positive gradient in the dose-response data can be attributed to this error, as an increase 
in cell viability with increased probe concentration is highly unlikely. The lack of a significant 
negative gradient suggests that the probe is non-toxic at working concentrations. 
 
3.3 Confocal Microscopy 
 
As in Chapter 2, an analogous probe was synthesised using the cresyl violet as the reporter 
(Figure 3.6). The fluorescent nature of the dye allows the probe to be imaged via LSCM, and 
because cresyl violet is structurally similar to methylene blue, it is assumed that this fluorescent 
probe behaves in a similar way to the methylene blue SERS probe.  





Figure 3.6: Cresyl violet probe fabricated for fluorescence microscopy. 
 
This cresyl violet probe without the selective peptide was incubated for two hours with both 
the NIH 3T3 cell line and the A375 cell line. Confocal microscopy images (Figure 3.7) show 
the interaction of the fluorescent probe with the cells. The fluorescent control probe (red) is not 
visible at all in NIH 3T3 cells, though some probe can be seen alongside A375 cells, despite 
the lack of a selective peptide. This is possibly due to the EPR effect.31 However, it is clear that 
significantly more probe is present in the A375 cell line when the A375 selective peptide is 
coupled, as shown in Figure 3.8. Even with this peptide present, none of the probe is visible in 
or around NIH 3T3 cells, suggesting good selectivity for the A375 cell line. The spots in the 











Figure 3.7: LSCM images of NIH 3T3 (left) and A375 (right) cells with the cresyl violet non-
specific control probe, overlaid with bright field transmission light microscopy images. 
Transmission λex 488nm; fluorescence λex 633 nm, λem 650-800 nm. The presence of a small 
amount of probe is evident from the red emission seen about the cells. 
 
 






Figure 3.8: LSCM images of NIH 3T3 (left) and A375 (right) cells with the cresyl violet 
A375-specific probe, overlaid with bright field transmission light microscopy images. 
Transmission λex 488nm; fluorescence λex 633 nm, λem 650-800 nm. Uptake of the probe is 
evident from the red emission seen inside the cells.  
 
3.4 SERS Testing with Human Melanoma Cells 
 
The effectiveness of the SERS probe in targeting human melanoma was evaluated against the 
cell line A375. Similar to tests carried out previously with MCF7 breast cancer cells, the 
selective probe was applied to cells by the method described in Chapter 6, and Raman spectra 
were collected. The cells were then rinsed with deionised water, and Raman spectra were 
collected again. If the selective SERS probe modified with the peptide NDP-MSH were to give 
SERS signals with human melanoma cells after rinsing, but ‘rinse out’ of other cells, giving no 
signal, this would prove that the probe is suitably selective to detect melanoma. Two controls 
were used; the control cell line NIH 3T3 (mouse skin fibroblasts), and a SERS probe with no 
peptide attached. These spectra are shown in Figures 3.9-3.12. Negative Raman intensities are 
a result of baseline correction carried out using MATLAB. 




Figure 3.9: SERS spectra of  NIH 3T3 cells dosed with non-selective control probe AuNS-
MB@SiO2, before and after rinsing. 
 
Figure 3.10: SERS spectra of  NIH 3T3 cells dosed with selective probe AuNS-MB@SiO2-
NDPMSH before and after rinsing. 





Figure 3.11: SERS spectra of  A375 cells dosed with non-selective control probe AuNS-
MB@SiO2 before and after rinsing  
 
Figure 3.12: SERS spectra of  A375 cells dosed with selective probe AuNS-MB@SiO2-
NDPMSH before and after rinsing. 





In Figures 3.9-3.11, the most prominent peaks are those at 663 and 866 cm-1, attributed to in 
plane and out of plane bending of C-H in methylene blue respectively.32 To be clear, for the 
purposes of this research a ‘prominent peak’ is defined as a peak in the SERS spectrum which 
is not present in the background spectrum of cells without any probe, and is significantly higher 
than background noise. This peak at 663 cm-1 also appears in Figure 3.12, though somewhat 
diminished. Figure 3.12 also has a prominent peak close to 866 cm-1, at 841 cm-1. It is not clear 
whether this signal also arises from methylene blue, but has shifted slightly, or whether this 
peak can be attributed to C-C stretching of the amino acid norleucine in the peptide chain.33 
Other prominent peaks of Figure 3.12 are those at 808, 1047 and 1154 cm-1 the latter two can 
be most likely attributed to in plane and out of plane bending of C-H bonds in methylene blue, 
respectively. The cause of the peak at 808 cm-1 is uncertain. Regardless of specific peak 
assignations, what is clear is that Figure 3.12 does not show significant reduction in Raman 
signals on rinsing. In Figures 3.9-3.11, the Raman spectra of cells between 500 and 1200 cm-1 
are flat- besides some minor noise- on rinsing, indicating that the probe is no longer present. 
However, in Figure 3.12, clear signals are visible after rinsing, indicating that the probe remains 
in the cell sample. The evidence therefore suggests that the Raman probe with selective peptide 
NPD-MSH does bind to A375 skin cancer cells. The lack of Raman signal in Figures 3.9-3.10, 
where a different cell line is used, and Figure 3.11, where a ‘control probe’ without NPD-MSH 
is used, suggest the probe is selective for A375 skin cancer cells, and that this can be attributed 
to the presence of the peptide.  
This suggests that the SERS probe designed and constructed as shown in Scheme 3.1 is suitable 
for the selective detection of skin cancer in humans. However, further research may be required 
to find a Raman reporter with stronger, clearer SERS signals. Nonetheless, this is a promising 
initial step towards a SERS-based melanoma diagnostic system, which would be an 
improvement on the current slow and speculative methods of diagnosis, and has been attempted 










1 Cancer Research UK, https://www.cancerresearchuk.org/health-professional/cancer-
statistics/statistics-by-cancer-type/melanoma-skin-cancer, (accessed 31 May 2020). 
2 R. P. Gallagher, B. Ma, D. I. McLean, C. P. Yang, V. Ho, J. A. Carruthers and L. M. 
Warshawski, J. Am. Acad. Dermatol., 1990, 23, 413–421. 
3 R. Zanetti, S. Rosso, C. Martinez, A. Nieto, A. Miranda, M. Mercier, D. I. Loria, A. 
Østerlind, R. Greinert, C. Navarro, G. Fabbrocini, C. Barbera, H. Sancho-Garnier, L. 
Gafà, A. Chiarugi, R. Mossotti and  for the H. W. Group, Br. J. Cancer, 2006, 94, 
743–751. 
4 F. M.-L. Robertson and L. Fitzgerald, J. cancer policy, 2017, 12, 67–71. 
5 M. Helfand, S. M. Mahon, K. B. Eden, P. S. Frame and C. T. Orleans, Am. J. Prev. 
Med., 2001, 20, 47–58. 
6 J. E. Mayer, S. M. Swetter, T. Fu and A. C. Geller, J. Am. Acad. Dermatol., 2014, 71, 
599.e1-599.e12. 
7 V. J. and C. L. and van D. A., Curr. Drug Targets, 2003, 4, 586–597. 
8 J. Wikberg, R. Muceniece, I. Mandrika, P. Prūsis, J. Lindblom, C. Post and A. 
Skottner, Pharmacol. Res., 2000, 42, 393–420. 
9 M. E. Hadley and R. T. Dorr, Peptides, 2006, 27, 921–930. 
10 E. B. Hawryluk and H. Tsao, Cold Spring Harb. Perspect. Med., 2014, 4, a015388–
a015388. 
11 R. M. Dores, Ann. N. Y. Acad. Sci., 2009, 1163, 93–100. 
12 N. K. Tafreshi, X. Huang, V. E. Moberg, N. M. Barkey, V. K. Sondak, H. Tian, D. L. 
Morse and J. Vagner, Bioconjug. Chem., 2012, 23, 2451–2459. 
13 J. E. S. Wikberg, Eur. J. Pharmacol., 1999, 375, 295–310. 
14 A. A. Rosenkranz, T. A. Slastnikova, M. O. Durymanov and A. S. Sobolev, 
Biochemistry. (Mosc)., 2013, 78, 1228–1237. 
15 W. Wang, D.-Y. Guo, Y.-J. Lin and Y.-X. Tao, Front. Endocrinol. (Lausanne)., 2019, 





16 A. M. L. Castrucci, M. E. Hadley, T. K. Sawyer, B. C. Wilkes, F. Al-Obeidi, D. J. 
Staples, A. E. de Vaux, O. Dym, M. F. Hintz, J. P. Riehm, K. R. Rao and V. J. Hruby, 
Gen. Comp. Endocrinol., 1989, 73, 157–163. 
17 J. Chen, M. F. Giblin, N. Wang, S. S. Jurisson and T. P. Quinn, Nucl. Med. Biol., 
1999, 26, 687–693. 
18 C. Haskell-Luevano, T. K. Sawyer, S. Hendrata, C. North, L. Panahinia, M. Stum, D. 
J. Staples, A. M. De Lauro Castrucci, M. E. Hadley and V. J. Hruby, Peptides, 1996, 
17, 995–1002. 
19 T. K. Sawyer, P. J. Sanfilippo, V. J. Hruby, M. H. Engel, C. B. Heward, J. B. Burnett 
and M. E. Hadley, Proc. Natl. Acad. Sci., 1980, 77, 5754–5758. 
20 Y. Yang, C. Dickinson, C. Haskell-Luevano and I. Gantz, J. Biol. Chem., 1997, 272, 
23000–23010. 
21 C. Haskell-Luevano, J. R. Holder, E. K. Monck and R. M. Bauzo, J. Med. Chem., 
2001, 44, 2247–2252. 
22 H. B. Schiöth, F. Mutulis, R. Muceniece, P. Prusis and J. E. S. Wikberg, Br. J. 
Pharmacol., 1998, 124, 75–82. 
23 M. F. Giblin, N. Wang, T. J. Hoffman, S. S. Jurisson and T. P. Quinn, Proc. Natl. 
Acad. Sci., 1998, 95, 12814–12818. 
24 V. B. Swope and Z. A. Abdel-Malek, Int. J. Mol. Sci. , 2018, 19. 
25 Y. Zhou, S. Mowlazadeh Haghighi, I. Zoi, J. R. Sawyer, V. J. Hruby and M. Cai, J. 
Med. Chem., 2017, 60, 9320–9329. 
26 S. Froidevaux, M. Calame-Christe, H. Tanner and A. N. Eberle, J. Nucl. Med., 2005, 
46, 887–895. 
27 Z. Cheng, J. Chen, Y. Miao, N. K. Owen, T. P. Quinn and S. S. Jurisson, J. Med. 
Chem., 2002, 45, 3048–3056. 
28 H. Chung, J. Lee, D. Jeong, I.-O. Han and E.-S. Oh, J. Biol. Chem. , 2012, 287, 
19326–19335. 




29 A. Lindskog Jonsson, A. Granqvist, J. Elvin, M. E. Johansson, B. Haraldsson and J. 
Nyström, PLoS One, 2014, 9, e87816. 
30 P. Eves, J. Haycock, C. Layton, M. Wagner, H. Kemp, M. Szabo, R. Morandini, G. 
Ghanem, J. C. García-Borrón, C. Jiménez-Cervantes and S. Mac Neil, Br. J. Cancer, 
2003, 89, 2004–2015. 
31 J. Fang, H. Nakamura and H. Maeda, Adv. Drug Deliv. Rev., 2011, 63, 136–151. 
32 G.-N. Xiao and S.-Q. Man, Chem. Phys. Lett., 2007, 447, 305–309. 
33 S. Stewart and P. M. Fredericks, Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 
1999, 55, 1615–1640. 
34      A. R. Kumar, K. B. Shanmugasundaram, J. Li, Z. Zhang, A. A. Ibn Sina, A. Wuethrich 























4. Molecular Wire Effects on Surface Enhanced Raman 
 
In 1959, prominent physicist Richard Feynman speculated that computers could one day shrink 
to nanoscale proportions. His lecture “There’s plenty of room at the bottom” discussed the 
possibility of circuits being built on a molecular scale, with single molecules constituting 
electrical components such as wires and resistors.1  It wasn’t until the 1970’s that the first 
research on the conductivity of molecules was published; one of the earliest instances of this 
being Bernhard Mann and Hans Kuhn’s 1971 paper reporting the conductivity of fatty acid 
monolayers on metal surfaces.2 Since then, the area of molecular electronics has grown 
massively in the pursuit of building ångström scale devices. In this chapter, another use for 
molecular wires is explored; the possibility of molecular wires being used as ‘antennae’ to 
amplify the surface enhanced Raman phenomenon.  
A molecular wire is defined as a molecule which conducts charge along its length. Some 
examples of these molecules include alkanes, oligophenylene ethynylenes (OPEs) and 
oligothiophenes; the conductive properties of these types of molecules are explored often in 
literature. In this chapter, it is proposed that the conductive properties of these molecules could 
be used to improve SERS signals.  
To understand how this might work, we must readdress the origins of the SERS effect. As 
mentioned previously, incident light on a solution of metal nanoparticles can induce a localised 
surface plasmon (LSP).3–5  When LSPs become confined by features such as crevices, points, 
or junctions between adjacent particles, they interact to form ‘hotspots’; areas of highly 
localised, intense electromagnetic fields, and it is in these hotspots that enhancement of the 
incident and scattered light occurs, resulting in the surface enhanced Raman effect. Here it is 
proposed that a molecular wire could conduct LSPs, extending the reach of the enhancing effect 
further from the metal surface, as surface plasmons are evanescent and decay exponentially 
from the metal surface. The molecular wire could in effect act as an antenna, overall 
augmenting the SERS effect. At this stage, this theory is speculative, though previous work 








4.1 Molecular Wire Design  
 
Careful consideration was taken into the design of molecular wires. First, the wire should 
contain a suitable anchoring group, to bind to the surface of gold nanostars in order to create a 
SERS probe. The backbone of the wire should be sufficiently conjugated to conduct charge, 
and give a strong Raman signal, acting both as a wire and Raman reporter in one. Finally, the 
wire should have a linker group to attach a selective peptide in order to bind the SERS target, 
as detailed in Chapter 3. The general structure is show in in Figure 4.1 
 
 
Figure 4.1: Schematic diagram of molecular wire SERS probe structure (not to scale). 
 
4.1.1 Anchoring Group 
 
In order to attach the molecular wire to a gold surface, the wire must possess a suitable 
anchoring group, as discussed in Chapter 1. Thiols tend to be the most common due to their 
ability to form self-assembled monolayers (SAMs) under mild conditions, without the need for 
any additional reagents.7 Furthermore, anchoring groups have a significant effect on the ability 
of a molecular wire to transport charge;  Au-SH anchoring groups have been shown to have 
greater conductance than Au-NH2 and Au-COOH, most likely due to superior bond strength.
7,8  
Although thiols have been shown to have the best aurophilicity of the many functional groups 
tested in the literature, many other sulphur containing functional groups such as thioacetates 
and thioethers will bind to gold in a similar way, as shown in Figure 4.2.9 The syntheses detailed 
in this chapter contain several different sulphur containing functional groups; starting materials 
were often altered if a reaction did not work, hence functional groups were changed slightly. 
The chosen functional group also depended on the cost of reagents.  
 





Figure 4.2: Mechanisms of sulphur-containing anchoring groups (top left- thiol; top right- 
thioether; bottom- thioacetate) binding to gold surfaces. 
 
 
4.1.2 Linking Group  
 
At the opposing end to the anchoring group, the molecular wire must possess a suitable linker 
for the selective peptide, in order to be used as a probe for melanoma detection. Molecules 
synthesised therefore contained amine or carboxylic acid terminal groups, in order to attach the 
peptide using a simple peptide bond-forming reaction, as in Chapter 3. Because these groups 
can also act as anchoring groups, it is important to use a very aurophillic anchoring group which 
can ‘outcompete’ the amine or carboxylic acid in binding to the gold surface. Another possible 
work-around for this problem is the ‘stepwise’ approach, discussed in section 4.1.3.  
 
4.1.3 Wire Backbone 
 
Two different backbone structures were synthesised; oligo(phenylene triazole) (OPT), and 
oligo(phenylene ethynylene) (OPE). These structures were chosen for their high levels of 
conjugation and ease of synthesis via coupling reactions. The general structures of these 
backbones are given in Figure 4.3, along with some other common molecular wire backbone 
structures. 
 





Figure 4.3: Example structures of common molecular wires. 
 
It was initially decided that the wires should be built ‘step-wise’ on the gold nanostar surface, 
as depicted in Figure 4.4. The first ‘building block’ of the oligomer would be attached to the 
gold surface via the anchoring group, forming a SAM. A coupling reaction could then be 
carried out on the gold surface, hence building the molecule step by step on the gold surface. 
This approach was deemed to be advantageous for several reasons. Firstly, should the final 
molecular wire product be insoluble, attaching the wire to the gold nanostars in the final stage 
of the probe synthesis would therefore prove challenging. It was also speculated that a stepwise 
approach would allow for more of the molecules to bind to the gold surface, as steric hindrance 
may prevent long-chain molecules from forming a closely packed monolayer. Finally, because 
the probe linking group could also act as an anchoring group, the stepwise approach could 
prevent wires attaching themselves to the gold surface ‘upside down’. The molecules were first 
synthesised on their own, without the gold nanostars, however the idea of using this stepwise 
approach to eventually construct a probe was taken into account in these initial syntheses, as 
reactions must have suitably mild conditions to be carried out on the gold surface without 
causing the nanostars to aggregate.  
 





Figure 4.4: Schematic diagram of the stepwise approach (left) compared to a direct 
approach (right). 
 
4.2 Molecular Wire Synthesis: OPTs 
 
The first set of novel molecular wires, OPT wires, were synthesised by combining an aromatic 
azide and alkyne using a 1,3-cycloaddition or Huisgen cycloaddition, to create the benzene-
triazole-benzene conjugated chain. This type of reaction was chosen as it is also known as a 
‘click reaction’.10–13 A click reaction is defined as a reaction which can occur under mild 
conditions, quickly, and with high yield. These mild conditions are ideal for building the wire 
stepwise on the gold surface. In order to synthesis these triazole wires, azides were synthesised 
for the coupling reaction with the alkynes. 
 
4.2.1 Azide synthesis 
 
The first azide synthesis attempted was a substitution reaction of 1,4-bromothiophenol using 
sodium azide. This method was adapted from that of Zhu et. al.14, though proved to be 
unsuccessful; it was quickly realised that due to the lack of an electron-withdrawing group, it 
was not possible for the SNAr addition-elimination reaction to take place as the appropriate 
intermediate cannot form. Because the electron-donating thiol is necessary as an anchoring 
group, a different approach had to be found.  
Azides were therefore synthesised from their analogous amines, using sodium nitrite and 
sodium azide. The mechanism for this is detailed in Scheme 4.1; in acidic conditions, the amine 
reacts with sodium nitrite to form a diazonium salt. The diazonium group then leaves and is 
substituted for the azide group by an aromatic SN
1 reaction. The reaction was initially attempted 
with 1,4-thioaniline, using a literature technique modified from Mach et. al.15, although this 




was unsuccessful. However, the same method did work using 1,4-methylthioaniline. The 
reason for this is unclear.  
 
Scheme 4.1: Synthesis of an aromatic azide from an amine. 
 
 
4.2.2 Azide-alkyne Click Reactions 
 
The general mechanism for the copper catalysed Huisgen cycloaddition, as proposed by 
Worrell et. al., is given in Scheme 4.2. A variety of novel molecular wire syntheses were 
attempted by adapting literature procedures;22 the proposed structures, starting materials, 
solvent, copper catalyst and accompanying co-catalyst used, and success of the reaction are 
summarised in Table 4.1.  





Scheme 4.2: The mechanism for the copper (I) catalysed Huisgen cycloaddition.16 
 
The Huisgen reaction is catalysed by Cu(I), however due to the instability of simple Cu(I) salts 
this is typically generated in situ from Cu(II) and the use of a co-catalyst to reduce the copper.17 
This is the case for reactions using CuSO4 and sodium ascorbate. However, this limits the 
reaction to aqueous conditions. The alternative catalyst [CuBr(PPh3)3] is a stable form of Cu(I), 
using bulky ligands to protect the copper centre from oxidation, negating the need for a co-
catalyst.18 It is important to protect the Cu(I) from oxidising agents, not only to allow the 
reaction to take place, but to prevent Cu(II) mediated alkyne homocoupling (known as the 
Eglinton reaction) from taking place to a form a diacetylene biproduct.19,20,21 It should be noted 
that alkyne homocoupling can also take place in the presence of a Cu (I) catalyst (i.e. Glaser 
coupling), although due to the nature of click reactions, the cycloaddition should be far 
preferable. This catalyst can be used in a wide range of organic solvents, making it useful for 
reactions with water-insoluble reagents.18 Another copper catalyst with the benefit of being 
soluble in a range of organic solvents is [Cu(CH3CN)4PF6]. This catalyst is used in conjunction 




with tetrabutylammonium difluorotriphenylsilicate (TBAT), a supporting ligand which binds 
to Cu(I) coordination sites to protect the metal centre from oxidation.22 [Cu(CH3CN)4PF6] is 
also often used with a base such as iPr2NH to aid deprotonation of the alkyne and subsequent 
formation of the copper-alkyne complex, as alkynes are not very acidic (this step is shown in 
the top-right of Scheme 4.2). There is some debate on whether this is necessary, as the 
formation of the acetylide is already fast without the need for further assistance, and the 
presence of a base may hinder the protonation of the triazole (this step is shown in the top-left 
of Scheme 4.2).19 However, a base was used in the syntheses detailed in this chapter, in 
accordance with most protocols in the literature.23 Table 4.1 summarises the outcomes of these 
syntheses. 
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PF6] / TBAT / 
iPr2NH 
MeCN Yes  
Table 4.1: Summary of molecular wire synthesis attempts 
 
Molecular wire 1 is the most straightforward of the proposed structures, combining 1,4-
azidothiophenol with a simple amine to act as a linking group. This synthesis was first 
attempted with CuSO4; a cheap catalyst and therefore a good starting point for the synthesis. 
The azide starting material was not soluble in water, and so mixtures of ethanol and butanol 
with water were attempted, though neither were successful due to poor solubility. 
[CuBr(PPh3)3] was therefore obtained as a catalyst in order to carry out the reaction in 
acetonitrile, which the azide did dissolve in. However, this reaction too did not go to 
completion for reasons which are unclear. It was decided that a number of different structures 
would be attempted to obtain a molecular wire product, and so procedures for structures 2-4 
were carried out. These structures are longer and more conjugated, incorporating an additional 
benzene ring, and so should act as more effective molecular wires.  
 
This first of these new designs, Structure 2, incorporates a carboxylic acid to act as a linking 
group. It would have been preferable to carry out this reaction using 4-ethynyl benzoic acid, as 
opposed to the meta isomer; this would have improved the conductive properties of the wire, 
as the presence of the carboxyl group on the meta position breaks the conjugation of the 
molecule, reducing electronic communication. Unfortunately, this isomer was not available to 
purchase. The synthesis of Structure 2 was again unsuccessful in aqueous conditions due to 
poor solubility. Despite the frequent use of [CuBr(PPh3)3] for click reactions in the literature, 
this catalyst again did not yield results, and so a third catalyst, [Cu(CH3CN)4PF6], was 
purchased. The synthesis of structure 2 with this catalyst was  successful, however, the product 
could not be used to functionalise gold nanostars due to its poor solubility in all of the standard 
solvents available. Although poor solubility would a make it impossible to attach the structure 
to a gold nanostar using a direct approach, a stepwise approach was attempted to overcome 




this, detailed in section 4.4. Following the apparent success of [Cu(CH3CN)4PF6] as compared 
to the other catalysts, all further reactions were attempted using this catalyst only. 
 
Structure 3 does not have a linking group, however, it was proposed that it would make a good 
Raman reporter nonetheless, as alkyne groups give strong Raman signals outside of the 
biological region. Again, it would have been preferable to carry out the reaction with the para 
isomer of 1,3-diethynylbenzene, though this reagent was unavailable to purchase. The only 
downside to the lack of a linking group is that when the final probe is constructed, a second, 
separate molecule would have to be added to the gold nanostars, alongside the molecular wire 
reporter, in order to bind the selective peptide, making the synthesis overall less efficient as an 
extra step would be required. Unfortunately, the synthesis never reached this stage, as the 
reaction yielded an unwanted bi-product caused 1-methylthio-4-azido-bezene reacting again 
with the initial product (Scheme 4.3), confirmed by a mass spectrometry M+1 peak at 457 m/z.  
 
Scheme 4.3: Formation of unwanted biproduct from Structure 3. 




Finally, the synthesis of Structure 4 was not only successful, but yielded a product soluble 
enough to work with. Going forward, this molecular wire would be used to construct a SERS 
probe.  
 
4.3 Molecular Wire Synthesis: OPEs 
 
An OPE molecular wire synthesis was also attempted. As previously mentions OPEs have a 
relatively facile synthesis by Sonogashira coupling; the palladium catalysed coupling of an 
alkyne and a halide alongside a copper cocatalyst, as shown in Scheme 4.4.  In addition, they 
have the benefit of an alkyne group, giving a strong Raman signal outside of the biological 
region, where it would not be obscured by other signals. For this reason, an OPE would make 
an ideal Raman reporter. Incorporating an alkyne into the backbone has the added benefit of 
increasing rigidity of the molecule. Research by Sukegawa et. al. suggests that increasing 
rigidity can improve the conductivity of a molecular wire due to electron-vibration coupling, 
although this study was conducted using the significantly more rigid carbon-bridged oligo-p-
phenylenevinylenes (COPVs).24  
 
Scheme 4.4: Catalytic cycle of the Sonogashira reaction. 
A synthetic route for a novel molecular wire Raman reporter was designed from a precursor 
OPE provided by Dr N. Sim (Scheme 4.5). Since the precursor already had an appropriate 
backbone, the only necessary steps were to convert the alcohol groups into thiol anchoring 
groups. In addition to the OPE backbone, the molecule features a carboxylic acid terminal 
linking group to bind a peptide, and two thiol groups to securely anchor the molecule to the 




gold surface. The extra thiol group has the added benefit of keeping the molecule in a more 
upright position on the gold surface; this is preferable to allow peptide coupling to take place 
on the terminal carboxylic acid group, which is less likely to occur if the wires are lying flat on 
the surface of the gold, sterically crowding the linking group. This upright position also ensures 
consistent binding geometry of the thiol; conductive properties of thiol anchored molecular 
wires have been shown to differ vastly due to the different possible binding geometries of the 
thiol, thus ensuring consistent binding will yield more consistent results.25 The syntheses given 
in Scheme 4.5 were assisted by Ms Y. Ermakova (4th year MSc. 2019/20). 
 
    Scheme 4.5: Synthetic route for OPE molecular wire  




The first step of this Scheme involves the conversion of the alcohol to a mesylate group, a 
considerably better leaving group than the alcohol. The mesylate is then substituted for thiourea 
via an SN2 mechanism, providing the C-S bond required to form the thiol. Finally, hydrolysis 
of the thiourea groups and the ester was carried out using three equivalents of NaOH, giving 
the thiol anchoring groups and terminal carboxylic acid in one step. The product was acidified 
to enable separation into the organic phase. The main product of this sequence, however, was 
not an alkyne but its alkene derivative, most likely formed in the acidification step. The 
mechanism for this reaction is given below (Scheme 4.6). Although it would have been 
preferable to repeat the reaction under different conditions to obtain the alkyne product, this 
was not possible due to time constraints caused by COVID-19. As the alkene is still a molecular 
wire, having a conjugated backbone, and will still give a Raman signal, it was deemed 
acceptable to proceed with this product. 
 
Scheme 4.6: Formation of 4‐{2‐[2,6‐bis(sulfonylmethyl)pyridin‐4‐yl]‐1‐ 
chloroethenyl}benzoic acid used in SERS experiments 
 
The position of the chlorine atom on the double bond was not determined due to time 
constraints. The addition of the hydrogen to the carbon atom closest to the benzoic acid group 




could give a more stable intermediate due to stabilisation of the carbocation by the p-benzoic 
acid group, although this is purely speculative. The configuration of the alkene was not 
determined as this is not relevant to its function as a molecular wire or Raman reporter. 
 
4.4 Functionalisation of Gold Nanostars 
 
The next step of the synthetic process was to attach the molecular wires to the gold nanostar 
surface, in order to test the theory of molecular wire augmented SERS. If the probes proved to 
be successful at this stage, they could then be further functionalised with a peptide and used in 
cell testing.  
Two methods were attempted for the functionalisation of gold nanostars with 4‐{1‐[4‐
(methylsulfanyl)phenyl]‐1H‐1,2,3‐triazol‐4‐yl}aniline (structure 4 of Table 4.1). The first was 
the stepwise method (Scheme 4.7) followed by the direct method (Scheme 4.8). A stepwise 
approach was also attempted for 3‐{1‐[4‐(methylsulfanyl)phenyl]‐1H‐1,2,3‐triazol‐4‐
yl}benzoic acid (structure 2, Table 4.1), as the poor solubility of this molecule made a direct 
approach impossible. It was therefore speculated that a stepwise approach could overcome this 
to yield structure 2 on the gold surface.  
 
Scheme 4.7: Synthetic route for building structures 2 and 4 stepwise on gold nanoparticles 
(not to scale). 
 





Scheme 4.8: Direct addition of structure 4 to gold nanostar surface (not to scale). 
 
After step one of the stepwise method (in which the self-assembled monolayer is formed), the 
mixture was centrifuged at 4000 rpm, the supernatant was decanted, and the nanostars 
resuspended to ensure the click reaction only occurred on the gold surface, and not with residual 
azide in solution. Despite the very mild reaction conditions of the click reactions, attempts at 
stepwise synthesis resulted in total aggregation of the gold nanostars. It is plausible that both 
1,4-azido(methylthio)phenol starting material, and any molecular wires which may have 
formed, could bind gold nanostars at both ends, facilitating aggregation. Aggregation could 
also be caused by hydrogen bonding of the terminal groups of molecular wires (Figure 4.5).   






Figure 4.5: Possible modes of aggregation during stepwise synthesis of molecular wires on 
gold nanostars.  
 
However, if the presence of the molecular wires were the cause of the aggregation, this would 
also be observed in the direct approach. Although some aggregation was observed in the direct 
approach (this was apparent, as the gold nanostar solution appeared to be a less deep shade of 
blue to the eye after the reaction was left overnight, suggesting that the nanostars were less 
evenly dispersed), the extent of this was much less than that of the stepwise approach, in which 
the nanostars aggregated completely, suggesting that the main cause was either the 1,4-
azido(methylthio)phenol, solvent, or the presence of TBAT and iPr2NH . Solvent is an unlikely 
cause, as PVP stabilised metal nanoparticles are well known to be stable in a wide variety of 




organic solvents, due to the amphiphilic nature of PVP.26–28 Evidence suggest that the presence 
of a base may accelerate degradation of PVP, thus decreasing stability of the particles.28 It can 
therefore be concluded that the presence of TBAT, iPr2NH and  1,4-azido(methylthio)phenol 
could all be the cause of aggregation; since these factors cannot be removed (particularly the 
azide, a key reactant), the stepwise approach was deemed not feasible. However, the direct 
approach proved successful for Structure 4. The Raman spectrum of the gold nanostars after 
the addition of the molecular wire (Figure 4.6) shows that the prominent peaks of the wire are 
present, indicating the molecular wire is bound to the surface. The nanostars were centrifuged, 
washed and resuspended in water 3 times to ensure that these signals are from the gold 
nanostars and not residual molecular wire in solution.  Negative Raman intensities are a result 
of baseline correction carried out using MATLAB. 
 
 
Figure 4.6: Raman spectra of 4‐{1‐[4‐(methylsulfanyl)phenyl]‐1H‐1,2,3‐triazol‐4‐yl}aniline 
on the surface of gold nanostars, and isolated as a solid. 
 
4‐{2‐[2,6‐bis(sulfanylmethyl)pyridin‐4‐yl]‐1‐chloroethenyl}benzoic acid was added to the 
gold nanostar surface via the direct approach. Again, some aggregation was visible by eye, as 
the gold nanostar solution was visibly less blue after stirring; this is likely caused by the 
carboxylic acid terminal group, causing aggregation in the same way as the previous molecular 




wire shown in Figure 4.5. Unfortunately, this aggregation resulted in few features in the Raman 
spectrum (Figure 4.7). The most prominent peak is at 398 cm-1, indicating PVP on the gold 
nanostar surface, followed by a slight broad peak about 1500 cm-1 caused by interference of 
the glass microscope slide below the sample.  There is a weak peak at 872 cm-1, which could 
be said to match the peak at 901 cm-1 in the spectrum of the isolated molecular wire; besides 
this, it is difficult to say if the molecular wire is indeed present on the gold surface.  
 
 
Figure 4.7: Raman spectra of 4‐{2‐[2,6‐bis(sulfonylmethyl)pyridin‐4‐yl]‐1‐ 
chloroethenyl}benzoic acid on the surface of gold nanostars, and isolated as a solid. 
 
 
4.5 Conclusions and Further Synthetic Work 
 
In summary, a number of synthetic methods were trialled in order to obtain a molecular wire 
on a gold nanostar surface; the effectiveness of these functionalised nanostars to amplify SERS 
signals is explored in the next section. It was initially speculated that a stepwise approach 
would be ideal, though this was unsuccessful; it is possible that removal of iPrNH2 from the 
reaction mixture could improve this, as studies show that basic conditions may be a cause of 
aggregation, and this reagent may not be essential to the success of the reaction. This could be 




investigated further, however was not explored at this time due to time constraints, and the fact 
that a satisfactory product was obtained by the alternative direct approach.  
The ‘probes’ constructed in this section are technically unfinished, consisting only of a gold 
nanostar and molecular wire reporter. To classify these as complete probes, it would be 
necessary to add the selective peptide. Before carrying out this final synthetic step, the effects 
of the molecular wires on SERS were investigated, and peptide coupling would be carried out 
if these tests were deemed successful. 
4.6 Enhancement Effects 
 
To assess potential SERS amplifying effects of molecular wires, it was necessary to create a 
suitable control. Control molecules should have two essential features; firstly, they must have 
the same functional groups as the molecular wires, thus giving similar Raman signals. In 
addition, they must be small molecules, allowing electronic communication over a much 
shorter range than the molecular wires synthesised in the previous section. A control molecule 
meeting these two requirements could be bound to a gold nanostar surface and compared to the 
molecular wire functionalised nanostars. It was theorised that if this ‘control probe’ were to 
give weaker SERS signals than the molecular wire functionalised nanostars, it could then be 
concluded that SERS signals are enhanced by molecular wires. 
The search for a suitable control molecule was a compromise between optimal structure and 
time. In an ideal world, a molecule would be synthesised with as much structural similarity to 
its analogous molecular wire as possible. However, given time constraints, it was more 
favourable to buy commercially available molecules than to synthesise new compounds.  
 
4.6.1 OPT Wire Controls 
 
For comparison with the OPT wire 4‐{1‐[4‐(methylsulfanyl)phenyl]‐1H‐1,2,3‐triazol‐4‐
yl}aniline (Table 1 structure 4), the first most simple control molecule proposed was 1,2,3-
triazole. It was speculated that the triazole could adhere to a gold nanostar surface via either 
lone pairs on nitrogen 2 or 3.29 It is not necessary for a control molecule to have a linking group, 
as a peptide will not be added at this initial testing stage. However, triazoles form very weak 
coordinate bonds with metals; it is therefore likely that it would be difficult to synthesise a 
stable AuNS-(1,2,3-triazole) colloid, as the washing step of the synthesis may remove the 
triazole from the surface all together. This was evident in Raman spectrum of AuNS-(1,2,3-




triazole) (Figure 4.8), which exhibited few strong features besides the characteristic PVP peak 
from the gold nanostars at 398 cm-1, and a peak from the glass microscope slide at 1377 cm-1. 
Negative Raman intensities are a result of baseline correction carried out using MATLAB. 
 
Figure 4.8: Raman spectrum of AuNS-(1,2,3-triazole). 
As well as its weak bonding, unfunctionalized 1,2,3-triazole is also a poor control due to its 
lack of a sulphur-containing anchoring group. Evidence shows that the anchoring group of a 
molecular wire has a significant impact on conductivity, and sulphur-containing anchoring 
groups in particular have excellent conductive properties.25,30 Therefore, a molecule with a 
different anchoring group to the molecular wire is not a suitable control. Additionally, the 
highly aurophillic nature of a sulphur-containing anchoring group will likely result in many 
molecules binding to the gold surface. In comparison, a molecule with a much less aurophillic 
anchoring group such as triazole will bind to the gold surface more sparsely. Therefore, the 
AuNS-OPT probe (AuNS‐S‐(4‐phenyl‐1H‐1,2,3‐triazol‐4‐yl)aniline) would likely give higher 
SERS signals than the AuNS-(1,2,3-triazole) control due to a higher number of molecules 
bound to the gold surface, as opposed to being a result of the conductive properties of the 
molecular wire. For these reasons it is essential to find a control with a similar anchoring group. 
Sodium 5-thiolate-1,2,3,-triazole was purchased from Fisher Scientific as an acceptable 




control. It was assumed that in solution, the thiolate ion would bind to gold in much the same 
way as any other sulphur-containing anchoring group. 
 It should be noted that this is not an ideal control, as the anchoring group is directly attached 
to the triazole. This is not the case in the original molecular wire, which has a benzene spacer 
between the anchoring group and the triazole. This difference in groups bonded to the triazole 
could affect the conductive properties of the triazole or even its Raman signals, thus making it 
a sub-optimal control.  However, inclusion of a benzene ring in the control molecule would 
make it a molecular wire, contradicting one of the key requirements of the control. Although it 
would be a shorter molecular wire than the original, and so the effects of wire length could be 
compared, the difference in length is not significant enough to make a decent comparison.  
 
Despite the aforementioned concerns, a control probe was synthesised from sodium 5-thiolate-
1,2,3,-triazole, as shown in Scheme 4.9. All control probes in this section were centrifuged, 
washed and resuspended in purite water three times before testing unless otherwise stated. The 
Raman spectrum of these functionalised gold nanostars is given in in Figure 4.9. Negative 
Raman intensities are a result of baseline correction carried out using MATLAB. 
 
 
                       
Scheme 4.9: Synthesis of AuNS-S-(1,2,3-triazole)  control probe  for comparison with AuNS‐
S‐(4‐phenyl‐1H‐1,2,3‐triazol‐4‐yl)aniline. 





                 Figure 4.9: Raman spectrum of AuNS-S-(1,2,3-triazole)  control probe. 
Despite the presence of sulphur in this triazole derivative, which should improve binding to 
gold, it is clear from the Raman spectrum that the molecule is not present on the gold surface 
(the peaks present at 399 cm-1 and 1363 cm-1 can be attributed to PVP and the glass microscope 
slide, respectively) and so AuNS-S-(1,2,3-triazole) was deemed an unsuitable control. The 
reasons for this are unclear, but it is possible that the presence of a salt may have caused  
aggregation of the nanostars (though little aggregation was observed by eye).  Following the 
unsuccessful results with triazole molecules, a new control probe was synthesised using an 
aniline derivative as a control molecule, as this fragment is also present in the molecular wire. 
The control probe was synthesised using 4-methylthioaniline (Scheme 4.10), and the Raman 
peaks of this molecule were visible on the gold nanostar surface (Figure 4.10). Notably, peaks 
at 1075, 1142 and 1437 cm-1 were prominent. Negative Raman intensities are a result of 
baseline correction carried out using MATLAB. 
 





Scheme 4.10: Synthesis of AuNS-S-(aniline) control probe  for comparison with AuNS‐S‐(4‐
phenyl‐1H‐1,2,3‐triazol‐4‐yl)aniline. 
 
Figure 4.10: Raman spectrum of AuNS-S-(aniline) control probe. 
 
4.6.3 OPE Wire Controls 
 
The original control molecule designed to complement this molecular wire was but-3-yne-1-
thiol. As the initial molecular wire design incorporated an alkyne bond to give strong Raman 
signals, so did the control design, as well as a thiol for binding the gold surface. Although two 
thiol groups would have been preferable, as this would make the control more structurally 
similar to the molecular wire, finding a molecule with this functionality from commercial 
sources was difficult and as previously mentioned, time for synthetic work was limited. The 
control molecule features a four-carbon chain, as it was speculated that a shorter molecule 
would be too volatile to work with. When it was discovered that the carbon-carbon triple bond 




of the molecular wire had been halogenated to yield an alkene, the same was done in the 
synthesis of the control molecule, so that alkene signals could be compared as opposed to 
alkyne. Hence the final control molecule became 2-chlorobut-3-ene-1-thiol. This synthesis of 
this molecule, given in Scheme 4.11, was assisted by Ms Y. Ermakova (4th year MSc. 2018/19). 
Gold nanostars were then functionalised with the molecule as shown in Scheme 4.12. 
 
 
Scheme 4.11: Synthesis of 2-chlorobut-3-ene-1-thiol. 
 
 
Scheme 4.12: Synthesis of control probe 3 for comparison with AuNS-S-(2-chloro-but-3-ene) 
 
Unfortunately, the Raman spectrum of this probe (Figure 4.11) also shows a lack of significant 
features, probably due to aggregation of the probe, as the nanostar solution became visibly 
paler on stirring, though the reason for this is unclear. Negative Raman intensities are a result 
of baseline correction carried out using MATLAB. 





Figure 4.11: Raman spectrum of AuNS-S-(2-chloro-but-3-ene) control probe. 
 
4.6.3 Enhancement Effects: Results 
 
Due to the poor stability of the AuNS-4‐{2‐[2,6‐bis(sulfanylmethyl)pyridin‐4‐yl]‐1‐
chloroethenyl}benzoic acid and its analogous control, this probe was not explored further. 
Raman spectra of AuNS‐S‐(4‐phenyl‐1H‐1,2,3‐triazol‐4‐yl)aniline and AuNS-S-(aniline) are 
given below (Figure 4.12). Negative Raman intensities are a result of baseline correction 
carried out using MATLAB. 





Figure 4.12: Raman spectra of AuNS‐S‐(4‐phenyl‐1H‐1,2,3‐triazol‐4‐yl)aniline (blue) and 
AuNS-S-(aniline). 
 
The most noticeable matching peaks which can be compared are those at 1080, 1142, 1184, 
and 1437 cm-1. It is clear that the peaks at these positions are not significantly larger than those 
of the control, and so we can conclude from this data that molecular wires do not enhance 
SERS signals in this instance. 
 
4.7 Conclusions and Further Work 
 
These experiments conclude that no noticeable SERS signal enhancement could be observed 
in the presence of molecular wires. However, it would have been valuable to try different wire 
structures and lengths. Of the two molecular wire functionalised AuNS structures synthesised 
in this chapter, only one could be tested against a control, due to instability of the gold nanostars 
in solution following the wire attachment step. Despite difficulties faced in this project, many 
different molecular wire monolayers have been constructed on gold surfaces in the literature.31–
34  It may be valuable to analyse the effect of these known molecular wire monolayers on SERS, 
as a more tried-and-tested system could prove more stable.  




In addition, constructing wires with a greater variety of lengths may have made for a more stark 
contrast, although this was not attempted in this project due to the challenges of synthesising 
long molecular wires, which can be highly insoluble. Although the control probes used in this 
chapter were sub-optimal, it is unlikely that a control probe with a closer structure to its 
analogous molecular wire would have yielded different results; clearly, the problem lies with 
the AuNS-molecular wire structures themselves, which gave poor Raman signals due to 
instability.  It was noted that the probes in this chapter appeared to have less visible aggregation 
when suspended in DMF as opposed to water, and so different solvents could have been 
explored to aid stability, although any probe deemed successful would need to be water soluble 
for biological compatibility in melanoma-targeting experiments.  
 
In addition, it may be useful take these experiments ‘back to basics’ by attaching the molecular 
wires to gold nanospheres, as opposed to nanostars. Simple gold nanospheres are known to be 
more stable than elaborate shapes such as stars.35 Use of a more reliable gold colloid may have 
improved stability; it could be said that starting with gold nanostars was too ambitious. 
However, time constraints would not allow these syntheses to be repeated with gold 
nanospheres. 
 
In conclusion, the idea that molecular wires could improve SERS signals could not be proven 
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The goal of this work has been to create a surface enhanced Raman probe for the selective 
detection of melanoma skin cancer. Melanoma is the deadliest type of skin cancer, though 
survival rates improve significantly when it is caught in the early stages; catching the disease 
early on is therefore vital to reducing mortality rates.1,2 Unfortunately, current diagnostic 
methods are invasive and rely on speculative examination of the lesion by an experienced 
clinician, taking up precious time and resources, as well as having potential for human error.3–
5 A rapid detection system could save time and circumvent the need for an expert, making 
diagnosis faster and more accessible, especially in areas where experienced specialists are 
scarce. 
 
SERS offers a promising alternative; having the potential for accuracy down to the single 
molecule, SERS could be used to detect biomarkers of cancer early in the disease.6,7 However, 
the use of this technique to detect melanoma has not been fully explored in the literature. 
 
5.1 Evaluation of the SERS probe 
 
A SERS probe was designed and fabricated using gold nanostars as the SERS substrate, 
methylene as a Raman reporter, a silica coating, and the linking group APTMS to bind the 
selective peptide [Nle4, D-Phe7]-α-MSH. This probe was applied to the human melanoma cell 
line A375, as well as the mouse skin fibroblast cell line NIH 3T3 (acting as a control), and 
Raman spectra of the cell samples applied to glass coverslips were recorded before and after 
rinsing the sample, to determine selectivity. Results in Chapter 3 show that when the probe is 
applied to the control cell line, the Raman signals of the reporter molecules are significantly 
diminished after rinsing, implying that the probe has not adhered to the cells. However, after 
rinsing A375 cells dosed with the probe, the Raman signals remain sufficiently prominent to 
suggest that the probe has bound to the target and is therefore selective. These results suggest 
that the probe has achieved its goal; a Raman signal is observed in the presence of melanoma 
cells, and when no melanoma is present, the unbound probe rinses away from the sample to 
give no signal. While this result is significant, the probe requires further optimization before it 
could be applied in a clinical setting.  
 




5.1.2 Structural Optimisation 
 
Further research into creating a gold nanostar core with a more controlled number of points 
could improve reproducibility. Although longer, sharper points could create a greater 
lightening rod effect, results showed that silica coating nanostars of this type resulted in large 
deposits of silica between points, which reduced SERS signals; further optimization of the 
silica coating method to address this could result in better enhancing effects. 
In Chapter 2, it was speculated that a SERS probe with a silica coating may give false-positive 
results in cells, as the hydrophilic nature of silica could facilitate probe adhesion to the cell, 
regardless of functionalisation with a peptide. It is possible that a SERS probe could be 
designed with a hydrophobic polymer coating, such that the probe would be repelled from the 
cell surface, unless forced into contact with a selective peptide, ensuring that there would be 
no false-positive results. The most obvious setback of this idea is finding a method to bind a 
hydrophobic polymer to gold nanostars, as such a polymer would have no suitable functional 
groups capable of binding to gold. Nonetheless, the prospect of eliminating false positives with 
a hydrophobic coating remains of interest, and given more time, this avenue could have been 
pursued further. Alternatively, the use of a different Raman reporter molecule which binds to 
the gold surface more strongly than methylene blue could negate the need for a surface coating 
all together (although the lack of a coating to provide space between the gold nanostars may 
result hotspot formation via aggregation of the stars, reducing reproducibility). 
  
5.1.3 Reporter Optimisation 
 
In Chapter 2 several NIR dyes were investigated as potential reporter molecules. Commercially 
available dyes were explored as these are easily obtainable, and utilise the SERRS effect when 
used alongside a 785 nm laser. Due to poor SERS signals and stability issues of other dyes 
bound to gold nanostars, only methylene blue was determined to be suitable. This dye does 
have many benefits, including being inexpensive, non-fluorescent (minimising background 
noise) and approved by the US FDA for medical use. Despite these advantages, to further 
optimise the probe it would be beneficial to find a molecule with stronger SERS signals. A 
molecule containing functional groups with vibrational frequencies outside of the biological 
window, such as an alkyne, could also improve spectral interpretation, as there would be 
minimal noise from the biological sample in this region. As mentioned previously, a molecule 




which binds covalently to the gold surface may prove beneficial as it would negate the need 
for a silica coating, which could improve Raman signals (as the SERS effect is distance 
dependent) as well as potentially reducing false-positive results. Furthermore, a molecule such 
as a thiol could form a densely-packed SAM on the gold nanostar surface, improving SERS 
signals by increasing reporter concentration. However, finding a SERRS reporter with all of 
these qualities would likely require a novel molecule to be designed and synthesised, while the 
use of the commercially available methylene blue would keep the cost of producing the probe 
to a minimum.  
 
5.1.3 Peptide Optimisation and Cell Lines 
 
The peptide [Nle4, D-Phe7]-α-MSH was chosen for its ability to target MC1Rs as shown in the 
literature. Although further research could have been done to find a peptide with optimal 
selectivity, Raman spectra in Chapter 3 show that SERS signals of the selective probe in 
melanoma cells are not significantly diminished on rinsing as they are in the control cell line, 
suggesting that this peptide is sufficiently selective.  
Of the many melanoma cell lines available commercially, A375 was selected as it has been 
proven to express MC1Rs, making it suitable for these experiments. However, microscopy 
images given in Chapter 3 show some uptake of the non-selective (peptide free) probe into 
A375. This suggests that some of the selectivity may be contributed to the EPR effect rather 
than the peptide. In order to fully rule this out, it would be beneficial to test the probe with a 
range of cancer cell lines from different types of cancer besides melanoma. Still, it is clear that 
there is a great deal more probe about the A357 cells when the peptide is present, so it is 
reasonable to assume that most of the selectivity is due to the peptide. The possibility of probe 
being taken up by other cancer cells via the EPR effect does present the possibility of false 
positive test results when melanoma is not present but another cancer such as squamous cell 
carcinoma is present. Therefore, any future work on this probe would require the researcher to 
define a minimum signal output for melanoma to be confirmed. 
 
5.2 Evaluation of Molecular Wire SERS  
 
It was speculated that molecular wires could possess the ability to enhance SERS signals. 
Previous work suggests that molecular wires are able to propagate evanescent waves from a 




metal surface with propagating surface plasmons.8 Following this, it was suggested that 
molecular wires could be used to extend the reach of the SERS effect further from the metal 
surface, effectively acting as antennae to improve SERS signals. 
 
Two molecular wires were synthesized and adhered to gold nanostar surfaces, along with 
‘control molecules’; shorter molecules with similar functional groups, which would therefore 
have similar peaks in their Raman fingerprints. ‘Molecular wire augmented SERS’ would be 
evident if the Raman intensities were significantly greater in the molecular wire SERS spectra 
compared to the SERS spectra of the control molecules. Overall, no such signal difference was 
observed.  
 
One of the major difficulties encountered in this chapter was the synthesis of stable molecular 
wire functionalized gold nanostars, as these had a tendency to aggregate, possibly due to 
various interactions of the wires between nanostars as discussed in Chapter 4. To counter this, 
more simple wires without terminal functional groups could be trialed, to minimize interaction 
between wires. However, a terminal functional group would eventually be a necessity, in order 
to bind a selective peptide and build a complete SERS probe, as in Chapter 3. 
 
 It is also possible that stability could be improved if simpler gold nanoshapes, such as 
nanospheres, were used, as these are generally more stable than nanostars. Overall, the 
possibility of molecular wire enhanced SERS could be known for certain if a more stable probe 
were fabricated, though this would take many optimization steps (including finding an ideal 
molecular wire and SERS substrate), which could not be fully explored in this work due to time 
constraints. 
 
5.3 Further Work  
 
In conclusion, the SERS reporter synthesized and tested in Chapters 2 and 3 can be classified 
as a selective probe in that Raman signals were observed in melanoma cells after rinsing, but 
not in control cells. In order to improve this probe, it would be beneficial to further optimize 
the nanostar core and reporter to maximise SERS output, though at this stage the results are 
promising. An optimized version of the probe presented in this work could then be tested with 
human tissue samples, and potentially progress to clinical trials in melanoma patients. Used in 




conjunction with a table-top Raman spectrometer, the probe could be used by any non-
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6.1 General Conditions 
 
Instrumental set up 
UV-Vis spectra were recorded with a UV-100 spectrometer, using a 1 cm quartz cell. Raman 
spectra were acquired using a Horiba Jobin Yvon LabRAM HR confocal Raman microscope, 
with a peltier-cooled CCD, 50× LWD objective lens, and diode laser. An excitation wavelength 
of 785 nm was used unless stated otherwise, with <1 mW laser power at the sample. TEM 
images were obtained by using a JEOL 2100F TEM. Samples for TEM were deposited onto 
carbon films on 200 mesh copper grids and allowed to air dry before use. Fluorescence 
emission spectra were recorded using a Horiba Jobin Yvon SPEX Fluorolog 3-22 
spectrofluorometer. NMR spectra were obtained using a Bruker Avance-400 spectrometer. 
Laser scanning confocal microscopy (LSCM) images were acquired with a Leica SP5 II LSCM 
confocal microscope with a HCX APO x63/1.4 NA Lambda-Blue objective. Excitation was 
633 nm, with an emission detection window of 650-800 nm, and scan speed of 100 Hz. 
Transmission images were collected using a 488 nm laser line. The field of view was 1024 x 
1024 pixels, with a pixel size of 98.5 x 98.5 µm.  
 
General Synthetic Conditions 
Standard starting materials were purchased from Sigma Aldrich. Peptides DMPGTVLP and 
[Nle4,D-Phe7]-α-MSH were purchased from Biopeptek Ltd. and GenScript Biotech 
respectively. Reactions were carried out at room temperature and in normal atmospheric 
conditions unless stated otherwise. 
 
6.2 SERS Probes with Dye-Based Reporters and Related Syntheses 
 
Citrate stabilised gold nanoparticles (AuNP)  
A 100 ml aqueous solution of sodium chloroaurate (0.01 wt. %, 0.01g) was heated to boiling 
and 7 ml sodium citrate added (1 wt. %, 0.07 g). The mixture was boiled for 30 mins until a 








Gold nanoparticle seed growth 
20 ml of AuNP seed solution was made up to 100 ml with water and the solution was heated 
to 65 °C, before adding 3 ml of sodium citrate solution (1 wt. %, 0.03 g). An aqueous solution 
of sodium chloroaurate (3 mM) was added dropwise until the desired absorbance was achieved. 
For AuNP with an average diameter of 62 nm (ʎ = 548 nm), 25 ml NaAuCl4 solution was added 
in total. The nanoparticle solution was centrifuged twice at 4400 rpm and resuspended in water.  
 
Silica coated AuNP (AuNP@SiO2)  
Following a modified Stöber method 2, the pH of a 20 ml solution of citrate stabilised AuNP 
suspended in water (ʎ = 548 nm, 0.02 mg cm-2) was adjusted to 10.5 by dropwise addition of 
ammonia. A 2 ml solution of tetraethylorthosilicate (TEOS) in EtOH (1 mM) was added 
dropwise over 1.5 h, and the mixture stirred was stirred for 24h. The nanoparticle solution was 
then centrifuged twice at 4400 rpm and suspended in EtOH:H2O (1:1). λmax(EtOH)/nm 530.  
 
AuNP@SiO2-(3-aminopropyl) trimethoxysilane (AuNP@SiO2-APTMS) 
A 10 ml solution of AuNP@SiO2 (0.02 mg cm
-2) was made up to 100 ml in EtOH:H2O (1:1) 
and adjusted to pH 10.5 by dropwise addition of ammonia. A 20 mM solution of 3-aminopropyl 
trimethoxysilane (17.4 μl) in EtOH was added and the mixture stirred for 3h at room 
temperature. The nanoparticle solution was then centrifuged twice at 4400 rpm and suspended 
in EtOH:H2O (1:1). λmax(EtOH)/nm 530. 
 
3-dansylpropyl trimethoxysilane (APTMS-DNS) 
Dansyl chloride (7 mg, 1 mmol) was dissolved in DCM, and 3-aminopropyl trimethoxysilane 
(4.5 mg, 1 mmol) was added. 9 μl tributylamine (1.5 mmol) was then 
added, and the mixture was stirred for 2 hours. The solvent was then 
removed in vacuo and filtered through a silica plug yielding the product 
as a yellow oil (18 mg, 67 %). 1H NMR (400 MHz, CDCl3): δH 0.54 (m, 
2H, H5), 2.93 (m, 8H, H1 and H3), 3.50 (s, 9H, H6), 7.22 (d, 1H, 
aromatic), 7.55 (m, 2H, aromatic), 8.26 (dd, 2H, aromatic), 8.55 (d, 1H, 








Au@SiO2-(3-dansylpropyl triethoxysilane) (Au@SiO2-APTMS-DNS) 
A 5ml solution of Au@SiO2-APTMS (0.2 mg cm
-2) was centrifuged and resuspended in 2 ml 
NaHCO3 buffer solution (pH 10, 25 mM). A 1 ml solution of dansyl chloride in acetone (20 
mM) was added and the mixture was stirred in the dark for 1h at 60°C. The nanoparticle 
solution was then centrifuged twice at 4400 rpm and suspended in EtOH. λmax(EtOH)/nm 320, 
530.  
 
Gold nanostars (AuNS): ‘one-step’ method 
5 g polyvinylpyrrolidone (PVP) was dissolved in 150 ml DMF with stirring at 8000 rpm. 240 
µl aqueous sodium chloroaurate solution (0.17 M) was added and a colour change from yellow 
to blue was observed within 30 mins. Particles were washed by centrifuging at 2400 rpm for 
20 mins. Excessive centrifuging was avoided to prevent aggregation.4 The supernatant was 
removed and particles were resuspended in purite water, and characterised using TEM. 
λmax(EtOH)/nm 976. 
 
Gold nanoparticle seeds (nanostar precursors for ‘two-step’ method) 
A 10 ml aqueous solution of sodium chloroaurate (1 mM) was brought to boil, and 1.5 ml of 
sodium citrate solution (1 wt%, 15 mg ) was added quickly. A colour change from yellow to 
red was observed immediately. The solution was refluxed a further 15 mins before cooling to 
room temperature.5 The resulting seeds were not centrifuged to minimise aggregation  
(additives in this synthesis were minimal and not detrimental to nanostar synthesis). 
λmax(H2O)/nm 527.  
 
Gold nanostars: ‘two-step’ method 
A 100 ml solution of sodium chloroaurate (0.25 mM in water) was stirred at 700 rpm with 100 
μl conc. HCl and 1 ml seed solution. 1 ml silver nitrate solution (2mM in water) and 500 μl 
ascorbic acid solution (100 mM in water) were added simultaneously, and a colour change 
from yellow to blue was observed within one minute. The nanostars were centrifuged for 15 









Silica coated gold nanostars with methylene blue Raman reporter and linker (AuNS-
MB@SiO2-APTMS)  
50 mg methylene blue was added to a 20 ml solution of AuNS suspended in purite water. The 
solution was stirred for 1h before centrifuging at 2400 rpm for 20 mins, to remove excess 
methylene blue. The particles were resuspended in 20 ml purite water, and the pH was made 
up to 10.5 by dropwise addition of ammonia. 1.5 ml tetraethyl orthosilicate (TEOS) solution in 
ethanol (5 mM) was added dropwise over 40 mins with stirring. The solution was stirred for a 
further 20 mins, before adding 5 ml (3-aminopropyl)trimethoxysilane (APTMS) solution in 
ethanol (10 mM) dropwise over 30 mins. The solution was stirred for 1h, and the particles were 
washed by centrifuging twice at 2400 rpm for 20 mins, resuspended in purite water, and 
characterised by TEM. λmax(EtOH)/nm 650, 974. 
 
Silica coated gold nanostars with methylene blue Raman reporter, linker and MCF7 
selective peptide (AuNS-MB@SiO2-APTMS-DMPGTVLP) 
A 20 ml solution of AuNS-MB@SiO2-APTMS, prepared as stated above, was resuspended in 
DMF and cooled to 0 oC.   0.5 mg of the peptide DMPGTVLP, 37 μL 4-dimethylaminopyridine 
(3.7 nmol) and 125 μL dicyclohexyl carbodiimide (60 nmol) were added. The solution was 
then allowed to warm to room temperature and stirred for 16 hr, before centrifuging at 4400 
rpm for 20 mins and resuspending in water. 
 
Silica coated gold nanostars with methylene blue Raman reporter, linker and A375 
selective peptide (AuNS-MB@SiO2-APTMS-[Nle4,D-Phe7]-α-MSH) 
A 20 ml solution of AuNS-MB@SiO2-APTMS, prepared as stated above, was resuspended in 
DMF and cooled to 0 oC.   A 100 μL solution of the peptide [Nle4,D-Phe7]-α-MSH in DMF (60 
nmol) , 37 μL 4-dimethylaminopyridine (3.7 nmol) and 125 μL dicyclohexyl carbodiimide (60 
nmol) were added. The solution was then allowed to warm to room temperature and stirred for 
16 hr, before centrifuging at 4400 rpm for 20 mins and resuspending in water. 
 
Silica coated gold nanostars with cresyl violet fluorescent reporter/ HITCI reporter and 
linker (AuNS-CV@SiO2-APTMS, AuNS-HT@SiO2-APTMS) 
Prepared in the same way as the methylene blue analogue, substituting methylene blue for 
cresyl violet and HITCI respectively. λmax-CV(EtOH)/nm 679, 974 λmax-HT(EtOH)/nm 674, 974. 
 




Silica coated gold nanostars with crystal violet fluorescent reporter/ HITCI reporter, 
linker and MCF7 selective peptide (AuNS-CV@SiO2-APTMS- DMPGTVLP, AuNS-
HT@SiO2-APTMS- DMPGTVLP) 
Prepared in the same way as the methylene blue analogue, substituting AuNS-MB@SiO2-
APTMS for AuNS-CV@SiO2-APTMS and AuNS-HT@SiO2-APTMS respectively. 
 
Silica coated gold nanostars with crystal violet fluorescent reporter, linker and A375 
selective peptide (AuNS-CV@SiO2-APTMS-[Nle4,D-Phe7]-α-MSH) 
Prepared in the same way as the methylene blue analogue, substituting AuNS-MB@SiO2-
APTMS for AuNS-CV@SiO2-APTMS. 
 
6.3 Molecular Wires and Related Syntheses. 
 
1,4-azido(methylthio)phenol 
Methylthioaniline (306 mg, 2.20 mmol) was dissolved in a 1:1 solution 
of water and HCl at 0 oC. Sodium nitrite (495 mg, 7.20 mmol) was 
dissolved in water (1 ml) and added dropwise, and the mixture was 
stirred for 1 h. The mixture was then poured into a solution of sodium 
acetate (4 g, 48.8 mmol) and sodium azide (508 mg, 7.82 mmol) in water 
(30 ml) and stirred 15 h. The product was extracted with DCM, washed with brine and dried 
over Na2SO4 before removing the solvent in vacuo to give 1,4-azido(methylthio)phenol as a 
yellow oil (225 mg, 62 %). 1H NMR (400 MHz, CDCl3): δH 2.40 (3H, s, CH3), 6.98 (2H, dd, J 
= 6.6, 2.1, H1 H2), 7.28 (2H, dd, J = 6.6, 2.1, H3 H4). Consistent with literature.6 
 
General method for synthesis of triazole molecular wires using CuSO4  
1,4-azido(methylthio)phenol (50 mg, 0.30 mmol) was dissolved in either a 1:1 solution of water 
and ethanol or t-butanol. Copper sulphate (1.26 mg, 5.04 x10-3 mmol, 2 %) and sodium 
ascorbate (9.98 mg, 0.05 mmol, 20 %) were added, followed by the appropriate alkyne (0.25 
mmol), before stirring 16 h at RT. Potential product was extracted with dichloromethane, 
washed with brine and NaHCO3 and dried over MgSO4 before removing solvent in vacuo.
7 
This method did not yield any product.  
 
 




General method for synthesis of triazole molecular wires using [CuBr(PPh3)3]  
1,4-azido(methylthio)phenol (50 mg, 0.30 mmol) and bromotris(triphenylphosphine)copper(I) 
(14 mg, 1.52 x10-2 mmol, 5 %) were dissolved in acetonitrile. The appropriate alkyne was 
added (0.30 mmol) and the mixture was stirred for 16 h at RT. Potential product was extracted 
with ethyl acetate and dried over MgSO4 before removing solvent in vacuo.
8 This method did 
not yield any product.  
 
General method for synthesis of triazole molecular wires using [Cu(CH3CN)4PF6] 
1,4-azido(methylthio)phenol (50 mg, 0.30 mmol) was dissolved in acetonitrile (50 ml) with 
tetrakis(acetonitrile)copper(I) hexafluorophosphate (56 mg, 0.15 mmol, 0.5 eq), 
tetrabutylammonium difluorotriphenylsilicate (81 mg, 0.15 mmol, 0.5 eq.), and 
diisopropylamine (168 μl, 1.2 mmol, 4 eq.). The appropriate alkyne was added (0.30 mmol) 
and the mixture was stirred 16 h at RT. Any precipitate formed was isolated via Buchner 
filtration and washed with THF.9 
 
3‐{1‐[4‐(methylsulfanyl)phenyl]‐1H‐1,2,3‐triazol‐4‐yl}benzoic acid 
 1,4-azido(methylthio)phenol (50 mg, 0.30 mmol) was dissolved in 
acetonitrile (50 ml) with tetrakis(acetonitrile)copper(I) 
hexafluorophosphate (56 mg, 0.15 mmol, 0.5 eq), tetrabutylammonium 
difluorotriphenylsilicate (81 mg, 0.15 mmol, 0.5 eq.), and 
diisopropylamine (168 μl, 1.2 mmol, 4 eq.). 4-ethynyl benzoic acid (44 
mg, 0.30 mmol) was added and the mixture was stirred 16 h at RT. A 
precipitate was isolated by Buchner filtration and washed with THF to 
yield the crude product as a green solid (70 mg, 75 %). m/z (ASAP) 
312 (M+, 100%). 1H NMR(400 MHz, DMSO): δH 5.77 (3H, s, SCH3), 
6.51 (2H, d, J = 12, H1 H2), 6.65 (1H, d, J = 8, H7), 7.11 (1H, d, J = 
8, H8), 7.14 (1H, s, triazole), 7.49 (2H, d, J = 12, H3 H4), 7.59 (1H, d, 










 1,4-azido(methylthio)phenol (71 mg, 0.43 mmol) was dissolved in 
acetonitrile (50 ml) with tetrakis(acetonitrile)copper(I) 
hexafluorophosphate (78 mg, 0.21 mmol, 0.5 eq), tetrabutylammonium 
difluorotriphenylsilicate (113 mg, 0.21 mmol, 0.5 eq.), and 
diisopropylamine (238 μl, 1.7 mmol, 4 eq.). 4-ethynyl aniline (44 mg, 
0.43 mmol) was and the mixture was stirred 16 h at RT. A precipitate 
was isolated by Buchner filtration and washed with THF to yield the 
crude product as a yellow solid (81.3 mg, 67 %) solid (70 mg, 75 %). 
m/z (ASAP) 283 (M+, 100%). 1H NMR (400 MHz, CDCl3): δH 3.40 
(2H, s, NH2) 5.32 (3H, s, SCH3), 6.62 (2H, d, J = 8, H7 H8), 6.68 (2H, 
d, J = 12, H1 H2), 7.59 (2H, d, J = 8, H5 H6), 7.84 (2H, d, J = 12, H3 





DIEA (217 mg, 1.68 mmol) was added to a mixture of  
methyl 4‐{2‐[2,6‐bis(hydroxymethyl)pyridine‐4‐
yl]ethynyl}benzoate. (100 mg, 0.336 mmol) and O(SO2CH3)2 
(293 mg, 1.68 mmol) in dry THF (2 ml) under argon and 
allowed to react with stirring for 2 h. The solvent was then 
removed in vacuo and the product was redissolved in DCM 
(10 ml) and washed with purite water (3 × 10 ml), then the 
combined organic phases were dried over Na2SO4 and solvent 
was removed in vacuo to give 3‐{1‐[4‐
(methylsulfanyl)phenyl]‐1H‐1,2,3‐triazol‐4‐yl}benzoic acid 
as a brown solid (125 mg, 82 %). 1H NMR (400 MHz, 
CDCl3): δH 8.08-8.11 (2H, m, H2 H3), 7.64-7.68 (2H, m, H4 
H5), 7.59 (2H, s, pyridine), 5.35 (4H, s, H7), 3.97 (3H, s, H1), 
3.16 (6H, s, H8). 
 
 




Methyl 4-(4-ethynyl-2,6-((carbamimidoylsulfanyl)methyl)pyridine)benzoate  
Thiourea (13 mg, 0.176 mmol) and methyl 4‐{2‐
[2,6‐bis(methanesulfonylmethyl)pyridin‐4‐
yl]ethynyl}benzoate (40 mg, 0.088 mmol) were 
dissolved in acetone (4 ml) and left to react for 48 h 
with stirring. A brown precipitate formed which was 
filtered off using a Buchner funnel and washed  
with diethyl ether to give methyl 4-(4-ethynyl-2,6-
((carbamimidoylsulfanyl)-methyl)pyridine)benzoate 
as the isothiouronium salt. (25.5 mg, 57 %). %). 1H 
NMR (400 MHz, CDCl3): δH 8.06 (2H, d, J = 8, H2 
H3), 7.76 (2H, d, J = 8, H4 H5), 7.68 (2H, s, H6), 






 Methyl 4-(4-ethynyl-2,6-((carbamimidoylsulfanyl)methyl)pyridine 
)benzoate (10 mg, 0.020 mmol) was dissolved in 2M aqueous NaOH (5 
ml) and heated at 80 °C in an argon atmosphere with stirring for 3 h. 
After cooling to room temperature the solution was acidified to pH 2 
with 2M HCl and extracted with DCM (3 × 10 ml). The organic phases 
were combined, washed with deionised water (3 × 10 ml), dried over 
Na2SO4 and the solvent removed in vacuo then passed through a Celite 
plug for purification to yield 4‐{2‐[2,6‐bis(sulfanylmethyl)pyridin‐4‐
yl]‐1‐chloroethenyl}benzoic acid as a green solid (3.3 mg, 52 %). 1H 
NMR (400 MHz, CDCl3): δH 8.11-8.12 (2H, m, H1 H2), 7.71-7.74 (2H, 
m, H3 H4), 7.54-7.56 (2H, m, H6), 7.02 (1H, s, COOH), 5.37 (4H, s, 
H7), 4.73 (1H, s, H5),  3.69 (2H, s, SH). Mass spectrometry and 13C NMR data of the final 
product could not be acquired due to COVID-19 restrictions. 
 
 





 Et3N(178 mg, 1.76 mmol) was added to a mixture of but-3-yn-
1-ol (49.3 mg, 0.703 mmol) and O(SO2CH3)2 (306 mg, 1.76 
mmol) in dry THF (2 ml) and under argon and left to react with 
stirring for 2 h. The solvent was then removed in vacuo and the 
product was redissolved in DCM (10 ml) and washed with deionised water (3 × 10 ml), then 
the combined organic phases were dried over Na2SO4 and solvent was removed in vacuo to 
give but-3-yn-1-yl methanesulfonate as a yellow oil (118 mg, 45 %). 1H NMR (400 MHz, 
CDCl3): δH 4.33 (2H, t, J = 6.69, H3), 3.08 (3H, s, H4), 2.68 (2H, dt, J = 2.68, 6.69, H2), 2.09 
(1H, t, J = 2.68, H1).  
 
3-Butyn-1-yl carbamimidothioate 
 Thiourea (130 mg, 1.70 mmol) and but-3-yn-1-yl 
methanesulfonate (118 mg, 0.796 mmol) were dissolved in 
acetone (4 ml) and left to react for 48 h with stirring. A white 
precipitate formed which was too fine to be filtered off. 
Solvent was decanted off and the precipitate was washed with 
DCM to yield 3-butyn-1-yl carbamimidothioate as the 
isothiouronium salt (55 mg, 60%). 1H NMR (400 MHz, CDCl3): δH 4.25 (2H, t, J = 6.36, H3), 
3.21 (3H, s, H4), 2.97 (1H, t, J = 2.63 H2), 2.63 (1H, td, J = 2.68, 6.36 H1).  
 
2-Chlorobut-3-ene-1-thiol 
 The isothiouronium salt of 3-butyn-1-yl carbamimidothioate (25 mg, 
0.119 mmol) was dissolved in 2M aqueous NaOH (5 ml) and heated at 
50 °C in an argon atmosphere with stirring overnight. After cooling to 
room temperature the solution was acidified to pH 2 with 2M HCl and 
extracted with diethyl ether (3 × 10 ml). The organic phases were combined, washed with 
deionised water (3 × 10 ml), dried over Na2SO4 and the solvent removed by gentle heating at 
atmospheric pressure. The resulting solid was washed with DCM to yield  
2-chlorobut-3-ene-1-thiol as a yellow powder (5 mg, 34 %). 1H NMR (400 MHz, CDCl3): δH 
4.70 (1H, s, SH), 3.69 (2H, s, H1), 3.60-3.62 (2H, m, H3), 3.26-3.30 (2H, m, H2). Mass 
spectrometry and 13C NMR data of the final product could not be acquired due to COVID-19 
restrictions. 
 




General method for the direct addition of molecular wires and control molecules to gold 
nanostars 
2 mg of the appropriate molecular wire or control molecule was added to a solution of AuNS 
in DMF as prepared in section 6.2 (20 ml) and stirred 16 h. The mixture was then centrifuged 
twice for 20 mins at 4.4 x103 rpm to remove excess reagent before resuspending in water (20 
ml).  
General method for the stepwise synthesis of OTP molecular wires on gold nanostars 
1,4-azido(methylthio)phenol (20 mg, 0.12 mmol) was added to a solution of AuNS in DMF as 
prepared in section 6.2 (10 ml) and stirred 16 h. The mixture was centrifuged twice for 20 mins 
at 4.4 x103 rpm and resuspended in DMF. Tetrakis(acetonitrile)copper(I) hexafluorophosphate 
(8 mg, 0.02 mmol, 0.5 eq), tetrabutylammonium difluorotriphenylsilicate (11 mg, 0.02 mmol, 
0.5 eq.), and diisopropylamine (24 μl, 0.17 mmol, 4 eq.) were dissolved in the suspension. The 
appropriate alkyne (0.04 mmol) was then added, and the mixture was stirred 16 h at RT before 
centrifuging twice for 20 mins at 4.4 x103 rpm and resuspending in water.  
6.4 Biological sample preparation 
 
Cell culture 
Cell lines used were NIH-3T3 (mouse skin fibroblasts), MCF7 (human breast cancer cells), 
and A375 (human melanoma cells) grown in Dulbecco’s Modified Eagle Medium with 10% 
foetal bovine serum. MCF7s were also supplemented with sodium pyruvate (1 %) and non-
essential amino acids (1 %). Cell were incubated at 37°C and 5% CO2 in average humidity. 
Cell harvesting was carried out by addition of trypsin solution (0.25 %) for 5 minutes at 37°C, 
before resuspending in fresh media. 
 
Cell samples for microscopy 
Cells were prepared by seeding into 24-well plates on glass coverslips and incubated at 37°C 
and 5% CO2 until 60-70 % confluent. The cell culture medium was then changed to Leydig 
Cell Medium, before adding 50 μl of a 0.5 mg cm-3 solution of the appropriate gold nanostar 
probe. These were incubated for the required time period at 37°C and 5% CO2. After washing 
with phosphate buffer solution, cover slips were mounted onto glass slides which were sealed 
with clear nail polish.10 
 
 




Cell samples for Raman spectroscopy 
Samples of cells at 107 cells ml-1 were centrifuged at 1000 rpm for 30 minutes to acquire cell 
pellets, which were then transferred onto glass slides. The cell pellets were soaked in an excess 
of a 0.5 mg cm-3 solution of the appropriate gold nanostar probe and allowed to air dry. After 
Raman spectra were acquired, the slides were washed with deionised water to remove unbound 
probe from the adhered cells before obtaining further Raman spectra. 
 
Toxicity Measurements  
Cells were seeded into 24-well plates and incubated in 5 % CO2 at 37 
oC until 80-90 % 
confluence was reached. The cells were then given fresh media and dosed with the desired gold 
nanostar probe, suspended in cell media, from a concentration of 0 mg cm-3 to 0.9 mg cm-3 
with intervals of 0.1 mg cm-3. After incubating for 24 h at 5 % CO2 and 37 
oC, the cells were 
harvested with trypsin and loaded into Via1-casette cell viability cartridges, containing DAPI 
and acridine orange for the detection of non-viable cells and live cells respectively. A 
ChemoMetec A/S Nucleocounter3000-Flexicyte was used to count live cells and measure cell 
viability of the samples using the Via-1 cassettes preloaded with DAPI and Acridine orange.11 
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